Biology Black Book
Biology Black Book
Biology Black Book
THE
BLACK
BOOK
ACEM I
2
Contents Page
Introduction 4-7
Appendices
Anatomy key facts 33-37
“It is said that if you know your enemies and know yourself, you will not be
imperiled in a hundred battles; if you do not know your enemies but do know
yourself, you will win one and lose one; if you do not know your enemies nor
yourself, you will be imperiled in every single battle.” - The Art of War, Sun Tzu
4
Introduction
Overwhelmed. This single word described my feelings as the stark realisation of what lay
ahead dawned on me. Four simple words - “Anatomy, Pathology, Physiology, and
Pharmacology” were to become the bane of my existence for the best part of 6 months. I
searched aimlessly for advice from my peers, and supervising consultants, only to
discover that everyone that had gone through this had different views on how to prepare
for such an exam.
The following guide is by no means revolutionary. It was born from one individuals
frustration, anger and self imposed isolation during the preceding months to the exam. It is
an evolution of advice and guidance I received from those I consider to be far wiser than
myself, along with a collation of other resources and summaries from various other
sources (mentioned below). The idea was to put all of this information in one place, thus
saving precious time for the more onerous task of revision. Rather than being a strict plan,
it was intended to be fluid, to evolve over time, so that subsequent exam candidates would
be free to add their pearls to this guide if they so wished.
Included in this guide is the core knowledge required from the major topics that will be
tested in the exam, and weighting of material in the guide is based on the current 2008
exam matrix provided by the college.
Due to time constraints, I have deliberately glossed over the topics that will feature as only
a cursory glance in the exam. The aim of this guide is to take you through the essential
study topics, allowing you to score heavily on those parts that will gain you the most
marks.
This programme is based on the assumption that in addition to your normal employment
duties, you will undertake an additional 20 -30 hours per week of study time.
Make no mistake, the commitment required is huge, and those who have other
commitments – i.e family and children will find this especially difficult. The whole process
can be thought of as a polygamous marriage between you, and the four recommended
textbooks, with the aim being to file for divorce after the programme is complete.
The key to this programme is using a problem-based approach. If you want to excel in
MCQs and vivas, then surely the best way is to practise MCQs and vivas, ad nauseum, in
the style of the exam. From personal experience, my level of recall was far less than ideal
when reading chapter after chapter in a book. By adopting a problem based approach, by
the time the exam comes around, it is likely that you will have covered many of the
questions you will be asked, during your preparation.
So, do as many MCQs as you can, and find a study partner to practise vivas with. Take no
prisoners. Tough love is the order of the day, and I advise you to push your study partner
5
as hard as you can, and vice versa. Push yourself to answer questions at a higher
standard than that which you will face in the exam.
Study Materials
Anatomy
Instant anatomy
Whitaker and Borley Blackwell Publishing, Incorporated; 3 edition (November 1,
2006)
Great book for revision in the weeks running up to the exam. Concise and packed with
useful diagrams and lists
Clinical Anatomy
Ellis
Blackwell Publishing; 11Rev Ed edition (Oct 2006)
This is a great book for general understanding of clinical anatomy. Ellis is truly a master.
Pathology
Physiology
Pharmacology
Miscellaneous
MCQ Primer For the ACEM Primary Exam
Volumes 1 & 2
Editor: Associate Professor Anne-Maree Kelly
Western Hospital 1998
These two gems are available from the Western emergency department – either give them
a call, or email them - Dr Zeff Koutsogiannis, Zeff.Koutsogiannis@wh.org.au
They are well worth borrowing from colleagues if they have them, or purchase your own.
They are key preparation tools, and I recommend that you do the relevant MCQs from
here as you go through the programme.
Be warned, there are some inconsistencies in the answers, and if you are unsure, it is
worth looking answers up to be sure.
8
APRIL-SEPTEMBER 2008
Week 1
Subject Topics Source Questions
material
Pharm Pharmacodyna Katzung • Definitions – Receptors, potency, efficacy, agonist,
mics antagonist, spare receptor
• Name different types of antagonist, and give
examples
• Draw – Dose response curves for agonist/
antagonist/partial agonist
• Describe different types of receptor, and give
examples.
• Describe mechanism of action of 2nd Messengers
with examples
Physiology Body Fluids Ganong • Definitions – osmosis, osmolality, osmolarity,
solute, diffusion
• Describe the distribution of water in the body, and
percentages in each compartment
• Describe the principles of measurement of ECF/
Plasma/Total body water
• Give values of intracellular/extracellular cations
and anions
• Describe the movement of ions across cell
membranes and the various pumps involved
Anatomy Tissues and Moore • Describe the structure of skin and glands
Structures • Describe the structure of hair
• Describe structure of muscles and tendons
• Describe structure of bone
• Describe comparative anatomy of a child
Week 2
Subject Topics Source Questions
material
Pharm Pharmacokineti Katzung • Definitions – VD, clearance, half life,
cs bioavailability, dosing rate, loading dose
• What factors affect the volume of distribution
• What is zero order and first order kinetics
• Give examples of drugs with high/low extraction
ratios
Physiology Nerve & Ganong • Define the resting membrane potential. How does
Muscle it arise?
• Describe ionic basis of action potentials.
• Describe the different types of nerve fibre, and
their susceptibility to hypoxia, pressure and local
anaesthesia
• Describe transmission of AP at synapse, and NMJ
• Describe how a muscle contracts – sliding filament
theory. SM/cardiac
Anatomy Nervous Moore • Describe layout of CNS/PNS
System • Components of autonomic nervous system
• Gross structure of brain and spinal cord.
• Describe segmental innervation in terms of
dermatomes/myotomes
• Be able to demonstrate dermatome distribution and
myotomes, and root values of major upper and
lower limb movements and reflexes
Pathology Inflammation Robbins • Describe the key features of acute inflammatory
response
• Describe the vascular response to injury
• Describe mechanisms of increased vascular
permeability
• Can you list the key inflammatory mediators of
inflammation
• What are the outcomes of acute inflammation
• What are the cell types involved in chronic
inflammation
• What are the morphological features of acute and
chronic inflammation
12
Week 3
Subject Topics Source Questions
material
Pharm Biotransformati Katzung • Describe biotransformation reactions in the liver,
on using paracetamol as e.g
• List phase 1, and 2 reactions
• List drugs that induce Cytochrome P450 pathways
• List drugs that inhibit Cytochrome P450 pathways
• Describe process of clinical trials
Physiology Nervous Ganong • Describe simple stretch/ withdrawal reflexes.
System • Describe sensory pathway of vision
• What is the reticular activating system
• Describe the functions of the hypothalamus &
temperature regulation
• Describe the ascending and descending tracts in
the spine
• Describe features of central cord syndrome/cauda
equina, cord transection
Anatomy Upper Limb I Moore • What is a girdle, how does it function?
Pectoral Girdle • Osteology of clavicle, scapula and humerus
Axilla • Describe the AC and sternoclavicular joint, +
ligaments
• Describe attachments and nerve supply of muscles
attaching limb to trunk
• Describe the blood supply to the breast
• Describe boundaries and contents of axilla
• Describe the scapular anastomosis
Pathology Healing and Robbins • Describe the process of wound healing, and scar
Repair formation
• What is healing by primary and secondary
intention
• What cells are capable of regeneration and can you
describe the cell cycle.
• Describe the process of fracture healing
• Describe the factors that affect wound and fracture
healing
• What is metastatic and dystrophic calcification?
13
Week 4
Subject Topics Source Questions
material
Pharm CV drugs I Katzung • List the Vaughn Williams classification for
Antiarrhythmic antiarrhythmic drugs
s • List the drugs in each class
Inotropes • Learn PK of Amiodarone
• Learn about mechanisms of additional drugs –
digoxin and adenosine
• Compare and contrast use of adrenaline/
noradrenaline/dopamine
• Which situations would you use the above drugs?
Physiology CVS I – heart, Ganong • Describe electrophysiological basis of ECG
cardiac cycle, & Guyton • Describe (Draw) AP of SA node and AV node, and
conduction compare with myocyte
• What is the ionic basis of AP in AV node, and the
diastolic pre potential
• Which fibres have the fastest and slowest
conduction
• Describe the cardiac cycle (draw). Volume
pressure loop.
Anatomy Upper Limb II Moore • Osteology of humerus
Upper Arm • Quadrangular and triangular space
• What muscles attach to the coracoid process
• What are the muscle attachments to the
intertubercular groove
• Describe the attachments and nerve supply of
biceps, coracobrachialis, brachialis, and triceps.
• What are the features contributing to stability of
shoulder joint?
Pathology Fluid Robbins • Describe the pathogenesis of oedema (starling
haemodynamic forces etc)
s • List different types of shock
• Describe pathogenesis of shock (detail on septic
and haemorrhagic)
• Definition of haemorrhage/ecchymosis/petechial
bleeding
• Define embolism/thrombus/infarction
• Can you draw the coagulation cascade and
describe main features
14
Week 5
Subject Topics Source Questions
material
Pharm CV drugs II Katzung • Describe pharmacological properties of nitrates
Anti-anginals • Describe pharmacological basis of calcium
Antihypertensi channel blockade using verapamil as an example
ves • Describe the main features of B-Blockers and list
different types, and the types of blockade that they
cause
• Discuss the side effects and toxicology of B
blockade (Propranolol)
Physiology CVS II Ganong • What is Poiseuille’s Law?
Physics of & Guyton • Describe laminar and turbulent flow
Flow • What is Reynolds number?
Pressure • What is compliance and distensibility of vessels?
Resistance • Describe Laplace’s law, and its relevance to
Vessels aneurysm formation
• Principle of autoregulation – myogenic theory,
local factors
Anatomy Upper Limb III Moore • Name the muscles /attachments/nerve supply of
Forearm the flexor compartment
• Name the muscles /attachments/nerve supply of
the extensor compartment
• What are the individual compartments of the
extensor compartment
• What are the boundaries and contents of the
cubital fossa
• Describe osteology of radius and ulnar. What is the
carrying angle?
• What is the axis of rotation for pronation/
supination
• Describe the ligaments around the elbow joint
Pathology Immune Robbins • Describe host barriers to infection. Outline innate/
System humoral immunity.
Neoplasia • What is the role of macrophage/B Cell/T cell in
immune response
• Outline the role of complement, and draw
complement cascade
• Define hypersensitivity reactions, describe, with
examples of each
• What is an oncogene? Define paraneoplastic
syndrome and give examples.
• Benign V malignant tumour and invasion.
• Discuss pathogenesis of common cancers - lung
15
Week 6
Subject Topics Source Questions
material
Pharm CV drugs III Katzung • Describe the pharmacological basis of different
Diuretics types of diuretic
• Indicate which part of the nephron different
diuretics act on
• Describe PK of frusemide, thiazides, carbonic
anhydrase inhibitor, as well as K sparing
• Toxicology/side effects of diuretics – and uses in
hypercalcaemia
Physiology CVS III Ganong • Describe reflex controls of BP – baroceptors
Control & Guyton • Describe physiological response to loss of 1L of
Autoregulation blood
Renin • Describe physiological response to infusion of 1L
angiotensin of normal saline
Aldosterone • Describe long term control of BP – RAA axis
• Discuss factors influencing CO and venous return
• Draw vascular function curves of Guyton and
Starling
• Discuss autoregulation in brain/kidney/coronary
circulation
Anatomy Upper Limb IV Moore • Describe the flexor retinaculum
Wrist • Describe the structure and layout of carpal tunnel
Hand • Describe extensor expansion, and function of
lumbricals (innervation too)
• Function of interossei and thenar/hypothenar
muscles (OAF)
• Nerve distribution to the hand
• Describe boundaries and contents of anatomical
snuff box
• Osteology of carpal bones
Pathology Infectious Robbins • Classification of bacteria
disease • Define virulence factors of staph. Aureus
• Describe pathogenesis of cholera/typoid/
salmonella
• Describe pathogenesis of HIV/herpes simplex/
CMV/Measles
• Describe different organisms involved in
pneumonia/meningitis/endocarditis and UTI
• Compare and contrast hepatitis A-D
16
Week 7
Subject Topics Source Questions
material
Pharm CV drugs IV Katzung • What are mechanisms of heparin/warfarin/aspirin/
Anticoagulants clopidogrel/TPA
• What is mechanism of Vit K
• Adverse effects of heparin
• Adverse effects of warfarin
• Interactions of heparin and warfarin
Physiology CVS – IV Ganong • Describe CSF circulation in the brain. How much/
CO/VR & Guyton where etc
Special • Describe coronary circulation – subendocardial/
circulations epicardial – flow during systole and diastole in RV
& LV
• Describe renal blood flow
• Describe pulmonary blood flow
• Learn table in Ganong with CO and flow through
various organs
Anatomy Upper Limb V Moore • Draw brachial plexus
NV • What is the course of median/radial/ulnar nerve in
Transitional arm and forearm
zones • What are branches of axillary artery? Where does
it start and end
• Describe the blood supply to hand
• Describe the venous drainage of upper limb
• Quadrangular/triangular space/Axilla/Cubital
fossa/Carpal Tunnel/anatomical snuff box
Pathology Blood vessels Robbins • Describe pathogenesis of atherosclerosis
• Describe pathogenesis of aneurysms and
classification
• What is aortic dissection?
• Describe pathogenesis of vessel wall damage
17
Week 8
Subject Topics Source Questions
material
Pharm Neuro I Katzung • Describe the classification of cholinoreceptors
• Describe the actions and give examples of
anticholinesterase inhibitors
• Describe the pharmacology of anticholinergics –
atropine
• Can you describe the classification of inotropes
• Describe the effects of adrenoceptors and
distribution in the body
Physiology Resp I Ganong • Describe gas transport in the lung
Structure and & West • What is anatomical dead space, and the Bohr
function equation
• Define lung volumes – draw curves, and describe
method of measurement
• O2 and CO2 transport in lung – concept of
diffusion v perfusion limited
• Where is most resistance in the airways?
Anatomy Lower Limb I Moore • Outline contents and boundaries of femoral
triangle
• Describe the different compartments of the thigh,
with muscles and nerve
• Describe the femoral canal/ring, and relations,
landmarks for fem art. Line
• What are the boundaries and contents of the
adductor canal?
• Describe the course of the sciatic nerve
• Describe the stability of the hip
• Osteology of pelvis and femur
Pathology Heart I Robbins • Pathogenesis of IHD/MI including risk factors and
distribution of thrombus
• Sequelae of AMI
• What is reperfusion injury
• What is the microscopic and macroscopic
morphology of MI?
• Describe the pathogenesis of bacterial endocarditis
and list the common pathogens.
18
Week 9
Subject Topics Source Questions
material
Pharm Neuro II Katzung • Describe pharmacological properties of lignocaine
LA and prilocaine
GA • Describe the pharmacological properties of
Muscle common agents – NO, Isoflurane
relaxants • What is the MAC?
• Classify muscle relaxants
• Pharmacology of suxamethonium vs atracurium.
Physiology Resp II Ganong • Describe regional differences in ventilation and
Ventilation and & West perfusion in the lung
diffusion • What is the alveolar gas equation?
• Can you classify the causes of hypoxia?
• Which cells synthesize surfactant, and what is its
function
• What is lung compliance? Can you give causes of
increased and reduced complicance?
Anatomy Lower limb II Moore • Describe the muscles / attachments/nerves of
Pelvis gluteals and lateral rotators
Lateral rotators • Define greater and lesser sciatic foramina, and list
what goes through each
• Relations and surface markings of the sciatic nerve
and piriformis
• Describe osteology of the pelvis
• Describe the ligaments of the pelvis, and the SI
joint.
• Which is stronger – anterior or posterior SI joint?
Pathology Heart II Robbins • Describe the morphology of cardiomyopathies
• What is pericarditis
• What are the common causes of pericarditis?
• What is rheumatic fever?
• Which antibodies are associated with rheumatic
fever?
19
Week 10
Subject Topics Source Questions
material
Pharm Neuro III Katzung • Describe the PK of thiopental/propafol/ketamine –
Sedatives side effects (ICP)
Anticonvulsant • Describe the mechanism of action of
s benzodiazepine
Etoh • Describe ionic/receptor basis for inhibition –
GABA Chloride channel
• Describe acute and chronic effect of alcohol
ingestion
• Describe tolerance with relation to ethanol
Physiology Resp III Ganong • Describe the pulmonary circulation
Blood flow & West • Describe the phenomenon of hypoxic
Metabolism vasoconstriction
Gas transport • What substances are metabolised/removed by the
lungs?
• How is CO2 and O2 transported in blood?
• Draw O2 and CO2 dissociation curves
• Explain Bohr Effect and Haldane Effect
Anatomy Lower Limb III Moore • Describe the boundaries and contents of the
Popliteal fossa popliteal fossa
Knee • Describe the knee joint
• Describe the action and significance of popliteus
• Which bursae communicate with the knee joint?
• What are offers stability to the knee joint and
patella?
• Describe the cruciate anastomosis around the knee
• Describe the knee capsule and ligaments
Pathology Lungs I Robbins • What is atelectasis?
Atelecatsis • Describe the pathogenesis and morphology of
Asthma asthma
COPD • Describe the morphology and pathogenesis of the
ARDS COPDs
• What types of emphysema are there?
• How does alpha 1 antitrypsin relate to
emphysema?
• What is the pathogenesis and morphology of
ARDS
• What are the most common causes of ARDS?
20
Week 11
Subject Topics Source Questions
material
Pharm Neuro IV Katzung • Describe the biogenic amine theory for depression
Antidepressant • Describe classification of antidepressants
s • Describe classification of antipsychotics
Antipsychotics • What are the adverse effects of the antipsychotics?
• What is serotonin syndrome?
• What is PK of lithium?
Week 12
Subject Topics Source Questions
material
Pharm ABx I Katzung • What is the mechanism of action of these agents?
Betalactam • Classify the cephalosporins into generations.
Aminoglycosid • What is the PK and toxicology of Gentamycin?
es • What is unique about doxycycline?
Sulphonamides • What is concentration dependent, and time
dependent killing?
• What is trimethoprim? What is it’s mechanism of
action and PK
Physiology Renal I Ganong • Describe structure and function of kidney –
& Vander medulla/cortex
• How would you measure renal blood flow? What
would you use?
• What is renal clearance and how is it measured?
• What factors affect GFR?
• What is the JGA?
• What causes mesangial contraction?
Anatomy Lower Limb V Moore • Describe the sensory distribution of the foot
Foot • Describe the layers of the sole
• Describe the arterial supply and venous drainage
of the foot
• What do the lumbricals of the foot do?
• Describe the components of the longitudinal and
transverse arches of the foot
• Osteology of the foot/ attachments
Pathology Renal I Robbins • Classify the main glomerular diseases
• Describe the pathogenesis of ARF/CRF
• What are the causes of ARF?
• What are the stages and outcomes of ARF?
• Post is post strep glomerulonephritis? How does it
present?
• What are the features of nephrotic syndrome?
22
Week 13
Subject Topics Source Questions
material
Pharm Abx II Katzung • Describe mechanism of action of macrolides
Macrolides • Erythromycin vs azithromycin
Quinolones • What pathogens do the macrolides target
Resistance • Describe the pharmacology of norfloxacin
• Describe the main mechanisms of bacterial
resistance
Physiology Renal II Ganong • Describe the features of ionic movements in the
& Vander nephron
• Describe the counter current multiplier system in
the loop of henle
• Describe the role and action of diuretics on various
parts of the nephron
• Describe the effects of vasopressin on the
collecting duct
• Describe hydrogen ion excretion and the kidney
• What is tubuloglomerular feedback?
Anatomy Lower limb VI Moore • Femoral triangle/adductor canal
Transitional • Popliteal fossa – boundaries and contents
Zones • Achilles tendon
Neurovascular • Distribution of saphenous veins
• Arterial supply to leg
• Superficial and deep inguinal nodes and what they
drain
Pathology Renal II Robbins • Pathogenesis and classification of renal stones
Calculi • List the main GU diseases
GU
23
Week 14
Subject Topics Source Questions
material
Pharmacol Abx III Katzung • Describe the treatment of TB
ogy TB • Describe PD and PK of acyclovir
Antivirals • What conditions can acyclovir treat?
Antiseptics • What is chlorhexidine and how does it work?
Physiology Acid Base Ganong • Describe major buffer systems in the ECF and ICF
Buffers (HCO3- etc)
• Derive the Henderson Hasselbach equation
• How does the lung and the kidney help regulate
acid base balance?
• What are the causes of metabolic acidosis?
• What are the causes of metabolic alkalosis
• What is the anion gap?
• Affects of exercise and altitude
Anatomy Head & Neck I Moore • Describe boundaries and contents of ant/post
Triangles of triangles of neck
neck • Describe the deep fascia in the neck.
Foramina of • Describe layers pierced for a cricothyroidotomy
skull • What are the branches of external carotid?
• List the foramina of skull and what go through
them
• Describe the osteology of typical vertebrae from
C/T/L spine
• Describe osteology of C1/2/atlantooccipital//
atlantoaxial joint
Pathology Liver Robbins • Describe the pathogenesis and morphology of
Cirrhosis alcoholic liver disease
Hepatitis • What are the sequelae of alcoholic liver disease?
• What are the causes of jaundice?
• Classify hepatitis A-D – features, carrier state etc
• What parasites can affect the liver?
• What is the pathogenesis of malaria?
24
Week 15
Subject Topics Source Questions
material
Pharm Analgesic Katzung • Describe the pharmacology of morphine/fentanyl
Drugs and naloxone
Opiates • What are the 3 different opiate receptors, and what
NSAIDS do they cause?
Paracetamol • What is the mechanism of action of ibuprofen?
• Describe PK and metabolism of paracetamol
• Describe management of paracetamol toxicity
Physiology Digestion and Ganong • Describe how carbs/protein/fat is absorbed and
absorption digested in the GIT
• What are the carriers for glucose/fat/proteins?
• Where are the vitamins ADEK absorbed?
• Where is iron absorbed?
• Where is the most water absorbed?
Week 16
Subject Topics Source Questions
material
Pharm Respiratory & Katzung • Describe the pharmacology of salbutamol and
GI aminophylline
• Describe the pharmacology of ipratropium
bromide
• Describe the pharmacology of sodium
cromoglycate
• Describe the pharmacology of corticosteroids
• Describe the pharm of PPI, and antiemetics
Physiology GIT Ganong • Describe how the GIT is regulated (Enteric
Nervous System)
• Describe factors affecting gastrin/gastric acid
secretion
• Describe the factors affecting insulin and glucagon
secretion
• Describe the composition of bile salts
• Describe the physiology of peristalsis
Anatomy Thorax I Moore • Describe the structure of the chest wall and
Heart and great intercostal space
vessels • Describe the divisions and contents of various
parts of the mediastinum
• Describe what levels the aorta/oesophagus/inf.
Vena cava enter the thorax
• Describe the course of the thoracic duct
• What are the relations of the first rib
• Describe landmarks for a ICC and what layers do
you go through?
• What are the surface markings of lungs and
pleura?
Pathology GIT Robbins • Describe the pathogenesis of Graves disease
Endo • Describe the pathogenesis of Diabetes Type 1 &2
• Describe the features of panhypopituitarism
• Describe the pathogenesis of Cushings/Conns/
Addisons
• Describe the pathogenesis of inflammatory bowel
disease
• Describe the pathogenesis of ischaemic bowel
26
Week 17
Subject Topics Source Questions
material
Pharm Autocoids & Katzung • Can you outline the current rational for migraine
endocrine treatment?
• How do antihistamines work?
• Describe the pharmacology of insulin and
glucagon
• Describe the adverse effects of Carbimazole
Physiology Endocrinology Ganong • Describe key steps in synthesis of thyroid
Thyroid hormones
Adrenal • Describe the synthesis of catecholamines and
Pancreas enzymes involved
Calcium • Describe the physiology of insulin effects on
adipose/muscle/liver
• Describe how calcium homeostasis is achieved
• What are the responses to hypocalcaemia/
hypercalcaemia
Anatomy Thorax II Moore • Describe the surface marking of the heart in the
Heart & Great anatomical position
Vessels • What makes up the right and left border on CXR
• Describe the blood supply to heart, and venous
drainage
• What is R & L dominance?
• Describe the aortic arch and relations to trachea
• Describe the internal surface of R atrium
• Describe relations of the trachea and blood supply
Pathology CNS Robbins • Describe the pathogenesis of CVA
• Describe pathogenesis of cerebral aneurysm
• Describe pathogenesis of meningitis viral and
bacterial
• What are non infective causes of meningitis
• Pathogenesis of common brain tumours
• Describe the pathogenesis of MS/Guillan Barre.
27
Week 18
Subject Topics Source Questions
material
Pharm Toxicology Katzung • Paracetamol
• Opiate
• Benzodiazepine
• TCA
• Anti depressants
• Use of charcoal
Physiology Metabolism Ganong • Describe metabolism pathways for carbs/protein/
fat
• What are the RQ values for brain/muscle?
Week 19
Subject Topics Source Questions
material
Pharm Old age/ Katzung • Pharmacological considerations of the elderly
Pregnancy • Which drugs should be used in caution in the
elderly?
• How does metabolism in the liver change in the
elderly
• Give examples of drugs that are not safe in
pregnancy
Physiology Blood Ganong • Describe the physiology of plasma and lymph
• Describe the ABO system for transfusion
•
If the venue is in your home city, it’s worth swinging by the exam venue in the run up, to
work out transport routes etc.
So, this means a suit for the guys, and something smart and conservative for the girls.
From personal experience – please don’t buy new shoes for the exam – unless they are
worn in, they can be very uncomfortable.
Don’t leave it until 2 days before the viva to dust off that suit in the closet. The stress and
intensity of the revision process may have caused you to gain/lose a few pounds.
You do not want to find out your suit is a poor fit on the morning of the exam.
Equipment
The only equipment you will require for the exam is a couple of 2H pencils, and a decent
eraser.
You may wish to take a watch into the exam, but there is usually a clock at the front of the
exam hall.
Paperwork
Do not forget you candidate photo ID or your viva timetable.
You will not be allowed into the examination hall without your photo ID.
Nothing should be new to you going into the exam, so make sure you have had a dress
rehearsal, ideally at the mock exam. Treat the mock as the real deal; it’s better for any
logistical errors to be made on that day, than the exam day itself.
Final Note
Remember, your preparation for this exam has been excellent. Therefore you will have an
excellent chance of passing whichever subjects you are sitting. It is quite normal to not feel
ready in the run up to the exam, and this is by no means an indication as to what your
performance might be.
Appendices
2. Pathology summaries
7. Notes
33
Axilla
Boundaries
Anterior – pec major/minor
Posterior – subscapularis, teres major, lat dorsi
Medial – serratus anterior, upper 3 ribs
Lateral – intertubercular groove of humerus
Apex – convergence of first rib, scapula, clavicle
Floor – Suspensory ligament
Contents
Axillary vessels and branches
Axillary nodes
Cords of brachial plexus
Fat
Quadrangular space
Boundaries
Superior – subscapularis
Inferior – teres major
Medial – long head of triceps
Lateral – humerus
Contents
Axillary nerve, posterior circumflex humeral artery and vein
34
Triangular space
Boundaries
Superior – teres major
Inferior – long head of triceps
Lateral - humerus
Contents
Radial nerve, profunda brachii
Cubital fossa
Borders
Superior – intercondylar line
Lateral – pronator teres
Medial – brachioradialis
Floor – brachialis, supinator
Roof – fascia, medial cubital vein
Contents
Lateral to medial – bicep Tendon, brachial Artery, median Nerve
Carpal tunnel
Boundaries
Flexor retinaculum
Carpal bones
Contents
Long flexors
Median nerve
Anatomical snuffbox
Boundaries
Radial – EPV, APL
Ulnar - EPL
Contents
Radial artery, cephalic vein, scaphoid, trapezium, radial nerve
Femoral triangle
Boundaries
Superior - Inguinal ligament
Lateral - Sartorius
Medial - Adductor longus
Floor – Iliopsoas, adductor longus
Roof – Fascia lata
Contents
Femoral nerve, artery, vein,
Femoral Nerve NOT in femoral canal
Adductor canal
Boundaries
Lateral – vastus medialis
Medial – adductor longus/magnus
Roof – Subsartorial plexus
Floor – adductor magnus
Contents
Femoral artery, vein, saphenous nerve, nerve to vastus medialis
Popliteal fossa
Boundaries
Superior lateral – biceps femoris
Superior medial – semitendinosus/membranosus
Inferior medial/lateral – heads of gastrocnemius
Floor – posterior capsule of knee, popliteus
Roof – fascia
Contents
Popliteal vessels, short saphenous vein
Tibial nerve, common peroneal nerve, sural nerve,
Lymph nodes and fat,
36
Vertebral landmarks
C3
Hyoid bone
C4
Bifurcation of common carotid
C6
Cricoid cartilage,
Start of trachea,
vertebral art. enters transversarium
T3/4
Top of aortic arch,
Manubrium
T4/5
Angle of Louis,
Bifurcation of trachea
T8
Diaphragm opening for IVC,
R phrenic nerve
T10
Diaphragm opening for oesophagus,
Vagi,
L gastric vessel
T12
Diaphragm opening for aorta,
Azygous/hemiazygous veins,
Thoracic duct,
Coeliac axis
L1
Transpyloric plane,
End of spinal cord,
Pylorus,
2nd part of duodenum,
Neck of pancreas,
Portal vein,
Hila of kidneys,
SMA origin
L1/2
Origin of renal arteries
L3
Origin of IMA
L4
Bifurcation of aorta
L5
Formation of IVC
38
Pathology Summaries
Necrosis
Cell death
Nuclear changes – pyknosis, karyolysis, karyorrhexis
Coagulative – solid organs, architecture preserved
Liquefactive – abscess
Caseous – TB
Fat necrosis – saponification, e.g pancreatitis
Apoptosis
Pathogenesis
Physiological – involution of tissues – thymus, death of immune cells, intestinal epithlia
Pathological – radiation, viruses, drugs, cancer
Initiation – intrinsic/extrinsic
Execution - Caspases
Morphology
Cell shrinkage,
Chromatin condensation
Fragmentation
Apoptotic bodies
Cellular blebbing
Lack of inflammation
Reperfusion Injury
Damage due to oxygen free radicals
Free radicals promote MPT
Ischaemia causes inflammation – neutrophil infiltrate – reperfusion increases local
inflammation
Activation of complement – IgM deposition, and subsequent inflammation
In MI – contraction bands due to increased IC calcium
39
Atherosclerosis
Pathogenesis
• Chronic endothelial injury, usually subtle, with resultant endothelial dysfunction, yielding
increased permeability, leukocyte adhesion, and thrombotic potential
• Accumulation of lipoproteins, mainly LDL, with its high cholesterol content, in the vessel
wall
• Modification of lesional lipoproteins by oxidation
• Adhesion of blood monocytes (and other leukocytes) to the endothelium, followed by
their migration into the intima and their transformation into macrophages and foam cells
• Adhesion of platelets
• Release of factors from activated platelets, macrophages, or vascular cells that cause
migration of SMCs from media into the intima
• Proliferation of smooth muscle cells in the intima, and elaboration of extracellular
matrix, leading to the accumulation of collagen and proteoglycans.
• Enhanced accumulation of lipids both within cells (macrophages and SMCs) and
extracellularly.
Morphology
Morphology. The key processes in atherosclerosis are intimal thickening and lipid
accumulation. An atheroma consists of a raised focal lesion initiating within the intima,
having a soft, yellow, grumous core of lipid (mainly cholesterol and cholesterol esters),
covered by a firm, white fibrous cap.
Outcomes
• Focal rupture, ulceration, or erosion of the luminal surface of atheromatous plaques
may result in exposure of highly thrombogenic substances that induce thrombus
formation or discharge of debris into the bloodstream, producing microemboli
composed of lesion contents (cholesterol emboli or atheroemboli).
• Haemorrhage into a plaque, especially in the coronary arteries, may be initiated by
rupture of either the overlying fibrous cap or the thin-walled capillaries that vascularize
the plaque. A contained hematoma may expand the plaque or induce plaque rupture.
• Superimposed thrombosis, the most feared complication, usually occurs on disrupted
lesions (those with rupture, ulceration, erosion, or hemorrhage) and may partially or
completely occlude the lumen. Thrombi may heal and become incorporated into and
thereby enlarge the intimal plaque.
• Aneurysmal dilation may result from ATH-induced atrophy of the underlying media, with
loss of elastic tissue, causing weakness and potential rupture, discussed later.
40
Aneurysm
Pathogenesis
Atherosclerosis
Hypertension
Matrix metalloproteinases.
A decreased level of tissue inhibitor of metalloproteinases (TIMP)
Morphology
True aneurysm – bounded by 3 vessel wall layers
False aneurysm – extravascular haematoma that communicates with intravascular space
Outcomes
• Rupture into the peritoneal cavity or retroperitoneal tissues with massive, potentially
fatal, hemorrhage
• Obstruction of a vessel, particularly of the iliac, renal, mesenteric, or vertebral branches
that supply the spinal cord leading to ischemic tissue injury
• Embolism from atheroma or mural thrombus
• Impingement on an adjacent structure, such as compression of a ureter or erosion of
vertebrae
• Presentation as an abdominal mass (often palpably pulsating) that simulates a tumor.
Aortic Dissection
Pathogenesis
Dissection of blood along laminar planes of aortic media, forming intramural blood filled
channel.
Hypertension, damage to ECM
Connective tissue disorders.
Morphology
Type A – proximal lesion involving ascending aorta
Type B – Distal lesion, usually distal to subclavian artery
Outcomes
Rupture
Haemorrhage
Death
41
MI
Pathogenesis
• The initial event is a sudden change in the morphology of an atheromatous plaque
• Exposed to subendothelial collagen and necrotic plaque contents, platelets undergo
adhesion, aggregation, activation, and release of potent aggregators including
thromboxane A2, serotonin, and platelet factors 3 and 4.
• Vasospasm is stimulated by platelet aggregation and the release of mediators.
• Frequently within minutes, the thrombus evolves to completely occlude the lumen of
the coronary vessel.
• Vasospasm
• Emboli: from the left atrium in association with atrial fibrillation, a left-sided mural
thrombus or vegetative endocarditis; or paradoxical emboli from the right side of the
heart or the peripheral veins which cross to the systemic circulation, through a patent
foramen ovale, causing coronary occlusion.
Feature Time
Onset of ATP depletion Seconds
Loss of contractility <2 min
ATP reduced
to 50% of normal 10 min
to 10% of normal 40 min
Irreversible cell injury 20-40 min
Microvascular injury >1 hr
Morphology
Gross
6-12 hours - no change
18-24 hrs - pale, cyanotic
1 week - yellow, softened
Hyperemic granulation
White fibrous Scar
Microscopic
1 hr – intercellular oedema
12-72hrs – hypoeosinophilia, coagulative necrosis, neutrophil infiltration
3-7 days – macrophages
7-10 days – granulation, then dense fibrous scar
Outcomes
Arrhythmia and sudden death.
Cardiogenic shock
CHF
Rupture of ventricle
Pericarditis
Mural thrombus
Aneurysm
Extension of infarct
42
ARDS
Pathogenesis
Alveolar damage, involving capillary endothelium and epithelium.
Increased cap. Permeability, oedema, fibrin exudate, hyaline membranes
Activated neutrophils
Activated macrophages
Loss of surfactant and compliance
Shock
Sepsis
Gastric aspiration
Trauma
Morphology
Wet, heavy lungs, red
Diffuse alveolar damage
Type 2 pneumocyte proliferation
Outcomes
Pulmonary oedema, respiratory failure, arterial hypoxemia refractory to oxygen therapy
Pneumonia
Pathogenesis
Congestion
Consolidation, red hepatization
Grey hepatization
Resolution
CAP – strep pneumoniae, haemophilus influenzae, staph aureus, Legionella,
Enterobacteriaceae, pseudomonas
Atypicals – Mycoplasma pneumoniae, Chlamydia, RSV, SARS
Immunocomp – CMV, pneumocysis jiroveci, mycobacterium avium intracellulare,
aspergillosis, candida
Morphology
Bronchopneumonia – patchy consolidation of parencyma. Lung shows suppuration,
consolidation. Neutrophil infiltrate
Lobar pneumonia – involves large portion of entire lobe
Outcomes
Abscess
Empyema
Fibrotic scar
Sepsis
43
Emphysema
Pathogenesis
Abnormal permanent enlargement of airspaces distal to terminal bronchioles, with alveolar
wall destruction.
Protease-antiprotease hypothesis
Increased elastase activity
Smoking activates alveolar macrophages
Morphology
Centrilobular – proximal/central acinus, upper lobe, apex, smokers
Panacinar – uniform destruction, lower, basal zone, a1 antitrypsin deficiency
Distal – distal acinus
Overinflated lungs
Enlarged alveolar airspaces
Outcomes
Respiratory failure
Infection
Asthma
Pathogenesis
Type 1 hypersensitivity
Reversible bronchial hyperresponsiveness, chronic.
Atopic – common, allergens, atopy, IgE, mast cell degranulation, eosinophilia
Non-atopic – infection, exercise, cold air, no IgE involvement
Morphology
Overinflated lungs
Atelectasis
Mucus plugs
Curschman spirals
Charcot leyden crystals
Smooth muscle and submucosal gland hypertrophy
Outcomes
Pneumothorax
Infection
44
PE
Pathogenesis
DVT – 95%, Diffuse alveolar damage, pulmonary hypertension, atheroclerosis
Virchows triad
Starling forces
Morphology
Large – death, cardiovascular collapse – 5%
Middle – 20-35% induce haemorrhage and infarction
Small – 60-80% - clinically silent, transient chest pain
Outcomes
Death
Chest pain
Infarction
Cor Pulmonale
Cirrhosis
Pathogenesis
Progressive fibrosis and reorganisation of vascular microarchitecture.
Collagen I, III deposition
Disruption of ECM
Causes – etoh, hepatitis, bilirary disease, haemochromatosis, Wilsons, a1 antitrypsin
deficiency
Morphology
Fibrosis
Nodules
Disruption of parenchyma
Myofibroblast proliferation
Outcomes
Hepatic failure
Portal hypertension – varices
Hepatocellular carcinoma
45
Pancreatis
Pathogenesis
Pancreatic duct obstruction – gallstones
Primary acinar cell injury – virus, drugs, trauma
Defective intracellular transport of proenzymes
Enzyme – trypsin activation, inappropriately, activates other enzymes – elastases
Causes - etoh, gallstones, infection – mumps, ERCP/surgery, shock,
Morphology
Proteolysis, lipolysis, haemorrhage
Oedema
Fatty necrosis
Outcomes
Resolution
Abscess
Pseuducyst
Chronic pancreatits
Graves
Pathogenesis
Most common cause of endogenous hyperthyroidism.
Hyperthyroidism
Exophthalmos
Pretibial myxoedema
Autoimmune process involving autoantibodies to TSH receptor
Morphology
Enlarged gland
Hypertrophy
Hyperplasia of follicular epithelium
Outcomes
Raised T4, T3, low TSH. Increased metabolism and iodine uptake.
46
Thiamine deficiency
Pathogenesis
Thiamine from diet, polished rice and flour have little
Absorbed from gut, used as enzyme cofactor for maintenance of neural membrane and
nerve conductance
Morphology
Myelin degeneration
Flabby heart
Mammillary body haemorrhage
Outcomes
Polyneuropathy
High output failure – Beri Beri
Wernicke-Korsakoff Syndrome
Shock (septic)
Pathogenesis
Systemic hypoperfusion from reduced CO or circulating volume, - hypotension, impaired
tissue perfusion, cellular hypoxia. Shock is the final common pathway for many lethal
events
Septic shock – spread of localised infection into blood
Gram –ve bacilli with LPS endotoxin
LPS alone can induce changes of septic shock
Activation of complement
Activation of cytokines – TNF, IL1
Systemic vasodilation
Dimished contractility
Widespread endothelial damage
ARDS
DIC
Morphology
Hypoxic tissue injury, end organ effects
Brain - hypoxic encephalopathy
Heart - coagulative necrosis, contraction bands
Kidneys – ATN
Lungs – seldom effected in hypovolaemia, diffuse alveolar damage in traumatic shock
Outcomes
Hypotension
Multi-organ failure
Death
Mortality of septic shock high.
47
ATN
Pathogenesis
Most common cause of ARF
Renal epithelial destruction due to ischaemia or nephrotoxins
Tubular damage
Arteriolar vasoconstriction
Tubular obstruction
Back leak of tubular fluid
Altered glomerular ultrafiltration
Morphology
Ischaemic ATN – patch tubular necrosis, proximal tubule and thick ascending LOH
Nephrotoxic ATN – tubular injury & necrosis, proximal tubule, other segments too
Distal tubules - protein and cellular casts. Mitotic figures and hyperchromatic nuclei
Outcomes
Initiation
Maintenance – renal failure and hyperkalemia
Recovery - hypokalemia
Prognosis good in nephrotoxic ATN
Staph. Aureus
Pathogenesis
Gram +ve cocci, grow in clusters
Cause skin infections, impetigo, osteomyelitis, pneumonia, endocarditis, food poisoning,
toxic shock syndrome
Virulence:
Surface proteins - adherence
Enzymes to degrade host proteins
Toxins - haemolysins, exfoliative toxins, enterotoxins, superantigens
VZV
Pathogenesis
Acute VZV causes chickenpox, reactivation causes shingles
VSV infects mucous membranes, skin, neurons and latent infection to sensory ganglia
Transmission via droplet, vesicular skin rash
Shingles when latent VZV in dorsal root ganglia becomes active – painful vesicular lesions
in dermatomal distribution
48
HIV
Pathogenesis
Retrovirus, destroys T cells
Lipid host derived envelope with a cone shaped electron dense core
Contains major capsid protein p24, nucleocapsid protein, genomic RNA, three enzymes –
protease, integrase, reverse transcriptase
Destruction of T cells
Altered macrophage function
Outcomes
CD4+ depletion
Opportunistic infection
CMV
Crytococcus Neoformans
TB
Pneumocystis jiroveci
Malignancy – lymphoma, KS, meningitis
Clostridium
Pathogenesis
Gram +ve bacillary anaerobes that produce spores
C. Perfringens – gangrene, food poisoning
C. Tetani – wounds, neurotoxin (tetanospasmin)
C. Botulinum – canned food, causes flaccid paralysis of respiratory and skeletal muscle
C. Difficile – pseudomembranous colitis in abx treatment
Viral Gastroenteritis
Pathogenesis
1-7 days, diarrhoea, anorexia, headache, fever
Rotavirus 25-65% worldwide
Caliciviruses
Enteric adenoviruses
Astroviruses
Morphology
Small intestine – shortened villi, lamina propria inflammation, enterocyte damage
49
Hepatitis B
Pathogenesis
DNA virus – hepadnavirus – Dane particle
Percutaneous, perinatal, sexual transmission 4-6 wk incubation
HBV infects hepatocytes, cellular injury due to immune response to liver cells CD8+ cells
mediate damage.
HBsAg appears before symptoms.
HBeAg HBV DNA
Outcomes
Chronic hepatitis – 5-10%
Carrier state
Cirrhosis
Hepatocellular Ca
Meningitis
Causes
Neonates – E Coli and group B strep
Infants and children – Strep pneumo, H. Infulenzae
Adults – Neisseria meningitidis
Elderly – Strep pneumo, listeria
50
It is a good idea that you learn these tables, and diagrams and are able to reproduce them
for the exam. They make excellent MCQ fodder.
Chapter 1
Figure 1-1 Body Fluid Compartments, Page 2
Table 1-1 Total body water in relation to age and sex, Page 3
Chapter 2
Figure 2-6, Action potential in a neuron, Page 55
Table 2-3, Relative susceptibility of mammalian A,B,C nerve to conduction block produced
by various agents, Page 61
Chapter 3
Figure 3-3, Sarcomere, Page 67
Chapter 4
Table 4-5, Physiologic effects produced by stimulation of opiate receptors, Page 113
Chapter 13
Table 13-2, Responses of effector organs to autonomic nerve impulses and circulating
catecholamines, Page 227
Chapter 14
Table 14-3, Summary of stimuli affecting vasopressin secretion, Page 245
Table 14-5, Body heat production and heat loss, Page 252
Chapter 17
Table 17-1, Factors affecting the metabolic rate, Page 281
51
Chapter 19
Table 19-3, Principal actions of insulin, Page 336
Chapter 24
Table 24-1, Factors that affect renin secretion, Page 458
Chapter 26
Table 26-3, Stimuli that affect gastrin secretion, Page 485
Chapter 28
Figure 28-1, Conduction system of the heart, Page 548
Chapter 29
Figure 29-2, Pressure volume loop of LV, Page 566
Chapter 30
Table 30-1 Characteristic of various types of blood vessels in humans,
Page 578
Chapter 31
Table 31-2, Summary of factors affecting calibre of arterioles, Page 603
Chapter 32
Table 32-1, Resting blood flow and O2 consumption in various organs,
Page 612
Chapter 33
Table 33-2, Cardiac output and regional blood flow, Page 634
Chapter 34
Figure 34-7, Lung volumes, Page 652
Chapter 35
Figure 35-2, Oxygen-haemoglobin dissociation curve, page 667
Chapter 38
Table 38-3, Agents causing contraction and relaxation of mesangial cells, Page 707
Chapter 39
Table 39-1, H+ concentration and pH of body fluids, Page 731
Photo
Axilla I
2/00
Median nerve I
1/00
Brachial plexus II
2/02, 2/04
Xray
Elbow III
1/97, 2/03, 2/04
Capsule & ligaments, vascular relations, ossification
Carpal bones III
1/97, 2/99, 2/04
Boundaries of ASB SA
Shoulder I
2/98
Stability
Wrist/hand II
2/03, 2/05
Identify bones & ligamentous attachments
Model
Forearm
Flexor IIIII
2/95, 2/97, 1/01, 1/02, 2/06
Middle finger flexion @ MCP, PIP & DIP II
55
Extensor I
2/97
Pronation/supination I
1/00
Hand
Extensor I
1/96
Palmar II
1/96, 2/99
Flexor tendons I
1/98
Thumb II
1/98, 2/99
Movement
Cubital fossa IIII
1/95, 2/98, 1/05, 1/06
Median nerve
AC & coracoclavicular joints I
1/97
Axilla
Brachial plexus II
1/97, 1/99
Shoulder joint I
2/98
Stability
Muscles involved in movement III
1/01, 1/02, 2/02
Pectoral girdle muscles I
1/04
Wrist
Carpal tunnel I
2/98
Elbow III
1/99, 1/01, 1/02
Stability, flex/ext
Biceps I
1/00
Forearm extension
Discussion
Wrist & hand I
1/95
Carpal tunnel SA IIII
1/99, 2/02, 1/04 2/06
Sensation ring finger I
2/00
Nerves involved in thumb movement II
2/01, 1/05
Sensory innervation of palm I
2/02
Dorsum of wrist I
1/03
Vascular supply I
2/03
Flexion of middle finger at MCP, PIP & DIP I
1/05
Cubital fossa II
1/95, 2/96
Venous drainage SA II
2/99, 1/03
56
Dermatomes I
2/04
Radial nerve lesion
Median nerve distal to elbow I
2/05
Lower Limb
Bone
Femur III
1/95, 2/98, 1/05
Blood supply to head
Pelvis IIIIII
1/96, 1/98, 1/99 x 2, 2/02, 2/05
Inguinal ligament, hip joint & ligaments, greater sciatic notch/nerve
Tibia I
1/96
Foot III
1/97 2/06
Photo
Femoral triangle I
1/00
Femoral nerve III
1/01, 1/02, 2/04
Femoral artery III
1/01, 1/02, 1/06
Back of thigh III
2/02, 1/04, 1/06
Course of sciatic
Xray
Foot III
2/95, 1/01, 1/02
Arch stability
Midtarsal joint I
2/99
Pelvis III
2/96, 2/98, 1/04
Course of ureters
Hip joint & pubis I
2/98
Knee IIII
1/00, 1/03, 2/04, 1/06
Ligaments
Ankle IIIII
1/01, 1/02, 1/05, 1/06, 2/06
Ligaments
Model
Knee joint IIIIIII
2/95, 2/97, 1/00, 2/03, 2/04, 2/05, 09/06
Stability, locking, patella stability & extension
Hip joint III
1/96, 2/98, 2/03
Blood supply & relations, stability & movements
Ankle joint IIII
2/96, 2/97, 2/98, 1/03
Nerves
Extensor ligaments I
2/99
57
Flexion/extension I
2/00
Inversion/eversion I
2/00
Anterior thigh
Femoral triangle II
2/96, 2/05
Femoral artery
Abductor canal I
1/97
Sciatic nerve I
1/97
Leg
Posterior compartment III
1/97, 2/00, 2/01
Peroneal compartment I
1/99
Neurovascular
Anterior compartment I
1/99
Neurovascular
Popliteal fossa III
1/98, 2/99, 2/01
Inguinal ligament I
1/98
Foot
Dorsum I
2/98
Discussion
Structures surrounding ankle II
1/95, 2/04
Great saphenous vein
Myotomes & reflexes SA II
2/99, 2/04
Common peroneal nerve lesion
Myotomes & femoral nerve I
1/06
Sensory innervation of sole I
2/02
Sensory innervation ankle/foot – dermatomes & peripheral I
2/03
Venous drainage I
1/04
Innervation great toe I
1/05
Peripheral, dermatomes & myotomes for same segment
Posterior compartment of the leg I
2/05
Achilles
2/00, 2/03
Stability & features
C2 II
2/97, 2/99
Ligaments
Typical – C6 II
2/99, 2/04
Thoracic vertebra II
2/00, 2/03
Stability, rib articulation
Mandible II
2/97, 2/99
Skull – facial bones II
2/04, 2/06
Infraorbital nerve
Photo
Sensory supply head & neck I
1/00
Face III
1/03, 1/05, 1/06
Face blood supply I
2/00
Lateral face/neck – muscles & innervation I
2/03,
blood supply – carotid arteries
Facial nerve II
1/04, 2/05
Anterior triangle I
1/05
SCM relationships
Xray
Cervical spine IIIIII
1/96, 2/97, 2/99, 2/00, 2/02, 1/05
Stability, head movements
PEG view II
2/02, 1/06
Facial II
2/97, 1/00
Infraorbital nerve
Mandible I
2/01
Zygomatic bone I
2/01
Orbital bones I
Infraorbital nerve
Skull I
1/98
Lumbar spine I
2/98
Model
Temporal region I
1/95
Triangles of neck I
1/95
Anterior I
2/99
59
Carotid
Larynx IIIII
2/95, 1/98, 2/99, 2/02, 2/04
Intrinsic muscles
Facial nerve & facial muscles II
2/96, 2/98
Carotid sheath I
2/96
Upper airway – tongue, pharynx, palate I
1/98
Tongue II
1/01, 1/02
Eye IIII
1/05
CN palsies
Structures & pupil reflexes II
1/05 2/06
Aqueous humour drainage I
1/06
Mandible/larynx I
1/05
Discussion
Face
Sensory supply II
1/99 2/06
Blood supply I
1/99
Extraocular muscles I
2/01
Muscles of mastication I
2/00
LP II
1/03, 1/06
CNS
Bone
Photo
Xray
Model
Discussion
Thorax
Bone
Rib II
1/97, 1/04
ICS landmarks & structures
1st rib I
2/05
Relationship of nerves & vessels
Photo
Thoracic inlet IIIIII
1/00, 2/01 x 2, 2/04, 1/05 2/06
Venous drainage of H&N/UL, arterial supply of head, IJV
60
Xray
CXR IIIIIII
1/95, 1/98, 1/99, 2/00, 2/02, 1/03, 1/05
Cardiac silhouette, SA of lung & pleura
Model
Intercostal space I
1/96
Arch of aorta II
1/96, 2/96
Heart IIIIIIII
1/97, 1/01, 1/02, 2/02, 1/04, 2/04, 2/05, 1/06
Blood supply, great vessels – PDA in newborn, chambers/valves
Blood supply of conducting system
Lung I
1/97
Discussion
Lung & pleura SA I
2/99
ICC insertion I
1/06
Abdomen
Bone
Photo
Ureters III
2/00, 1/03, 2/05
Posterior abdo wall – course & branches of aorta II
2/02, 2/03
Vasculature
Venous drainage I
1/05
Xray
AXR IIIII
2/96, 1/99, 2/00, 1/04, 2/05
Renal tract, course of abdominal aorta, soft tissues
CT – relations of the spleen 2/06
CT – relations of Liver II
Model
Retroperitoneum
Kidneys & ureters II
2/95, 2/98
Upper abdo – liver I
2/97
Abdominal aorta II
2/98 2/06
Branches & distribution
Spleen I
2/98
Discussion
61
Inflammation
Cells of immune system I
2/96
Macrophages I
1/95
Neutrophils I
1/96
Leucocytes (role) I
1/01
Chemical mediators of (acute) inflammation III
2/95, 1/99, 2/02
Chronic inflammation I
1/98
Acute inflammation
Vascular response II
2/03, 1/06
Wound repair
Skin wound healing IIIIIIII
1/95, 1/98, 2/98, 1/02, 2/02, 1/04, 2/04, 1/05
1° vs 2°
Pathologic factors influencing I
62
1/00
Angiogenesis I
2/04
Fibrosis & scar formation II
2/04, 1/05
Immunity
T Cells II
1/00, 2/00
B Cells II
1/01, 1/03
Complement system II
1/02, 1/03
Hypersensitivity I
1/95
Type I IIII
1/98, 1/99, 2/00, 1/02
Mediators inv
Type II (transfusion) IIII
1/99, 2/00, 1/01, 2/05
Type III III
2/99, 2/03, 2/05
Type IV I
2/99
AIDS II
2/96, 2/99
HIV abnormalities of immune function I
2/98
Virus & transmission II
1/01, 2/03
Infectious diseases
Host barriers I
2/95
Viral
Mechanisms of cell injury I
1/02
VZV III
2/01, 2/05, 1/06
Bacterial
Mechanisms of cell injury I
1/02
Clostridial infections II
1/01, 1/04
Tetanus II
1/95, 2/98
Staphylococcal II
2/95, 2/99
Streptococcal infections III
1/96, 1/00, 1/04
Meningococcus I
1/02
TB III
2/98, 2/03, 1/05
1°
Anaerobes I
2/99
Protozoa
Malaria II
2/01, 2/03
Neoplasms
Benign vs malignant II
1/95, 2/99
Benign I
2/97
Invasion of ECM I
1/05
Metastasis I
1/05
Paraneoplastic I
1/05
Genetics
Cardiovascular
Atherosclerosis IIIII
1/95, 2/99, 1/01, 2/01, 1/03
Microscopic features of atheroma I
1/00
Aneurysms II
1/95, 1/04
Aortic
AAA I
2/04
Aortic dissection I
64
2/04
MI IIII
1/99, 1/00, 2/01, 2/03
Infective endocarditis II
2/00, 2/02
Essential hypertension I
2/01
Hypertensive heart disease I
1/03
Pericarditis
Acute I
2/03
AS – calcific I
2/04
Cardiomyopathy
Hypertrophic I
1/06
Haematology
Anaemia I
2/95
Haemolytic II
1/97, 1/99
Microcytic I
2/97
Blood groups III
1/95, 2/96, 1/98
Transfusions I
2/96
Leucopenia I
1/97
Respiratory
APO I
1/96
ARDS III
2/96, 1/01, 1/04
Asthma IIIIII
2/96, 1/98, 1/00, 1/02, 1/04, 1/06
COPD I
1/97
Emphysema III
2/98, 2/00, 1/06
Chronic bronchitis I
1/99
Restrictive lung disease I
1/97
PE III
1/98, 1/00, 2/02
Pneumonia III
1/99, 2/99, 2/00
Legionella III
1/01, 2/02, 1/05
Atypical I
1/03
Influenza I
1/05
GIT
Bacterial enteritis II
65
2/01, 2/02
Salmonella II
2/04, 1/06
Cholera II
2/04, 1/06
Gastroenteritis I
2/04
IBD
Crohn’s I
2/05
Ulcerative colitis I
2/05
Ischaemic bowel I
2/05
Hepatobiliary
Ascites I
2/95
Hepatitis
Serum markers I
2/98
Pathogenesis I
2/98
Fulminant I
2/01
HAV I
2/05
HBV III
1/97, 2/02, 2/05
Serology II
1/96, 1/04
HCV III
1/00, 2/01, 2/02
Chronic viral I
2/01
Alcoholic I
2/02
Cirrhosis II
1/97, 1/05
Portal hypertension I
1/05
Jaundice IIII
2/97, 2/98, 2/99, 2/00
Cholelithiasis I
2/02
Pancreas
Acute pancreatitis IIIII
2/96, 1/98, 2/02, 1/04, 1/05 2/06
Chronic pancreatitis I
2/96
Renal
Calculi IIII
1/95, 1/99, 2/02, 1/06
Renal failure
Hypertensive I
2/96
Acute renal failure I
2/96
66
Pyelonephritis II
1/99, 2/00
Acute tubular necrosis III
1/00, 1/02, 1/06
Obstructive uropathy I
1/00
Analgesic abuse nephropathy I
2/00
Post streptococcal GN I
1/06 2/6
Joints
OA II
1/98, 2/05
OA vs RA I
2/01
RA I
2/05
Gout I
2/05
Musculoskeletal
Fracture healing IIIIIII
1/96, 2/98, 2/00, 2/01, 2/02, 1/03, 1/05
Pathologic factors affecting
Avascular necrosis I
2/01
Environmental
Radiation injury III
1/95, 2/97, 2/03
Thermal burns I
2/95
Air pollution & lung injury I
2/97
Cigarette smoke constituents I
1/01
Smoke effect on lung I
2/03
Heroin I
2/03
Endocrinology
Thyroid
Hyperthyroidism I
2/97
Thyroiditis I
2/98
Grave’s disease I
1/06
IDDM III
1/98, 1/04, 1/06
NIDDM I
1/06
Neurology
Nerve repair III
2/98, 2/00, 1/03
Meningitis I
2/00
Non-bacterial I
1/03
67
Pharmacology Topics
Pharmacodynamics
Agonist vs antagonist IIII
1/98, 2/99, 1/02, 2/03
Antagonists
Mechanisms I
1/95
Reversible vs Irreversible – response curves I
1/96
Potency & Efficacy IIII
2/95, 1/98, 1/05, 1/06
Define
Dose-response II
2/02 2/6
Receptors I
2/96
Interactions I
2/98
Second messengers IIIII
2/98, 2/99, 2/03, 2/04 2/6
Variations in drug responsiveness II
1/04, 1/05
Cellular basis I
1/00
Pharmackinetics
Definition I
2/01 (aspirin)
Volume of distribution IIIIII
1/95, 1/99, 2/00, 2/01, 1/03, 1/06
Vd/Loading dose; TCA OD
Half life IIII
2/95, 2/98, 2/00 2/6
Loading dose I
1/96
Absorption II
2/02, 2/05
First pass effect II
1/97, 1/04
Bioavailability II
2/03, 1/05
Clearance I
1/97
Elimination kinetics IIII
1/99, 2/00, 1/02, 1/06
Elimination I
2/02
Metabolism & influence on dosing I
2/05
Steady state I
2/97
In elderly I
2/04
Biotransformation IIIII
2/96, 2/99, 1/00, 1/03, 2/05
68
Antibiotics
Mechanisms I
1/00
Resistance II
1/00, 2/05
β-lactams I
1/95
Penicillin III
2/03, 1/05 2/6
Allergy & SEs
Flucloxacillin I
2/99
Cefalosporins III
2/96, 1/02, 2/04
Antiobiotic acting of cell wall I
2/98
Acting on protein synthesis I
2/98
Macrolides IIII
2/95, 1/99, 2/00, 1/05
Azithromycin
Tetracyclines IIII
1/96, 1/98 (PID), 1/03, 1/04
Aminoglycosides III
1/97, 1/99, 2/03
Choramphenicol I
2/97
Quinolones IIIII
2/00, 2/01, 1/03, 1/04, 2/04
Ciprofloxacin I
2/98
Sulfonamides IIII
2/01, 1/02, 1/05 2/6
Antiprotozoals
Metronidazole I
1/98
**Rx of diverticulitis – Metronidazole”
Anti-TB I
1/97
Antivirals I
2/96
Acyclovir II
2/97, 2/00
Opiates II
1/04, 2/05
Bioavailability I
1/95
Toxicity I
2/02
Morphine vs pethidine I
1/98
Pethidine I
2/00
Receptors I
1/99
Fentanyl I
69
1/00
ANS
Atropine I
1/01
Cholinomimetics
Indirect I
2/03
Muscarinic blockers I
2/03
Adrenaline II
2/95, 1/01
Dopamine I
1/97
Atropine II
2/96
Simpathomimetics I
2/05
β-Agonists I
2/03
β-Blockers IIIII
2/98*, 1/99, 2/01, 2/04, 1/06
Atenolol II
2/00, 2/02
Carvedilol I
1/05
Neuro
GA
Thiopentone III
2/99, 2/01, 102
Propofol III
2/99, 1/01, 1/03
Ketamine II
1/01 2/6
Halothane I
2/00
Nitrous oxide II
2/01, 1/06
NM blockers
Suxamethonium IIIII
1/95, 2/99, 2/00, 1/03, 1/06
Non-depolarising muscle relaxants I
1/96
Vecuronium I
2/00
Suxemethonium vs vecuronium I
1/98
LA I
2/04
Lignocaine IIIII
2/99, 1/02, 2/02, 2/04, 1/05
Bupivicaine I
2/01
Topical I
1/06
Antidepressants
TCA
Pharmacodynamics I
2/95
70
MAOIs III
2/96, 1/01, 1/04
SSRIs III
2/98, 1/01, 1/04
TCA vs SSRI I
1/99
Lithium I
2/05
Anticonvulsants I
2/05
Carbamazepine III
2/96, 2/98, 2/02
Phenytoin vs diazepam I
1/98
Phenytoin IIII
1/98, 2/98 (vs diazepam), 1/99, 1/00
Valproate I
1/05
Antipsychotics
Phenothiazines I
2/02
Chlorpromazine I
1/97
Haloperidol II
1/97, 1/98
Olanzepine I
1/06
Side effects I
1/05
Sedative-Hypnotics
Benzodiazepines III
2/00, 2/02, 2/05
Midazolam II
2/99, 2/04
Parkinson’s & movement
Benztropine II
1/01 2/6
Alcohol
Chronic toxicity I
2/02
Methanol I
1/05
CVS
Antiarrhythmics
Sotalol I
2/95
Amiodarone IIII
1/97, 2/99, 1/04, 1/06
Class I II
2/96 2/6
Adenosine IIII
2/96, 2/99, 1/03, 2/05
Antihypertensves
ACEI – captopril IIIII
1/96, 2/98, 2/00 (&AAs), 1/02, 1/03
AIIA I
2/05
71
Nitroprusside I
1/98 “IV control of HT”
Vasodilators – Antianginals
Antianginals II
2/98 (βB), 1/00
Nitrates II
2/02, 2/04
CCBs IIIII
2/96, 1/98, 1/99, 2/02 2/6
Verapamil I
2/01
Diuretics
Frusemide III
2/99, 1/02, 2/04
Anti-failure I
1/00
Cardiac glycosides III
1/04, 2/04, 1/06
NSAIDs etc
Aspirin IIIII
1/95, 1/99, 2/00, 2/01, 2/03
Toxicity I
1/06
Indomethacin II
1/97, 2/01
COX2 inhibitors II
2/03, 1/05
Colchicine I
1/97
Paracetamol III
2/01, 2/04, 2/05
Endocrinology
Insulin III
1/95, 2/04
Oral hypoglycaemics III
1/01, 1/03, 2/03
Glucagon II
2/03, 2/05 (role as antidote)
Corticosteroids
Prednisolone II
2/96, 1/01
Hydrocortisone II
2/97, 2/03
Toxicology
Methods of ↓absorption from GIT I
1/95
Immunisations
Hepatitis immunisation I
1/95
Active vs passive I
2/95
Respiratory
Inhaler I
1/06
Salbutamol III
72
1/95, 1/01
Ipratropium bromide II
2/95, 2/02
Cromoglycate I
2/02
Methylxanthines I
2/02
GIT
TPN I
1/96
Ranitidine vs omeprazole I
2/98
Antiemetics I
1/05
Metoclopramide I
2/01
Laxatives I
2/05
Anticoagulants
Warfarin III
2/97, 2/99, 1/06
Heparin IIIII
2/97, 2/99, 2/00, 1/03, 1/06
Antiplatelet drugs III
2/03, 1/05 2/6
Vit K I
1/06
Thrombolysis I
2/99
Streptokinase vs t-PA I
2/98
Age III
2/98, 1/00, 2/04
Histamine
H1 & H2 antagonists I
1/02
H2 antagonists I
1/04
H1 antagonists I
2/04
NO donors etc
Nitric acid I
1/05
Ergot alkaloids
Anti-migraine I
2/05
73
Neurology
AP III
1/03, 1/04, 1/05
Nerve cell conduction
Ion flux III
1/96, 2/99
Electrophysiology I
1/01
Ions & fibre type II
1/00, 2/01
Sensory pathways III
1/95, 1/99, 2/00
Motor pathways I
2/00
Stretch reflex IIIIIII
2/95, 1/00, 2/01, 1/04, 1/05, 1/06 2/06
Visual pathway II
2/95, 1/99
Nerve types & function II
1/96, 1/00
Cholinergic synaptic transmission III
2/99, 2/02, 2/04
NA synaptic transmission III
2/99, 2/02, 2/04
ADH/vasopressin II
1/02, 2/03
Temperature regulation I
2/05
Muscle
Contraction/relaxation events
Skeletal muscle IIII
1/96, 1/97, 2/98, 2/02
And length-tension II
2/00, 2/01
Smooth muscle (visceral) I
2/98
NMJ transmission III
1/97, 1/01, 2/04
Excitation-contraction I
74
1/05
Length-tension I
2/00
Circulation
Plasma composition I
1/95
Autoregulation I
1/95
Cerebral I
1/98
Pressure/flow/resistance II
1/95, 2/05
Laminar flow (Reynolds) I
1/99
AP & contraction IIII
2/98, 2/00 (V), 1/02 (V), 2/05
Cardiac cycle IIIIIII
1/95, 1/97, 1/00, 2/01, 2/02, 2/03, 1/05
Factors controlling CO IIIIII
2/95, 1/00, 2/01, 2/02, 2/03, 1/04
Their interaction with control of BP I
2/98
Factors influencing contractility (Frank-Starling) III
2/95, 2/97, 1/06
Effect of exercise II
1/96, 1/99
Capillary fluid exchange II
1/96, 2/98
Chemoreceptors I
2/96
Baroreceptors II
2/96, 2/04
Conducting system of heart I
1/97
BP control
Medulla II
2/97, 2/98
Neural II
2/00, 2/01
Humoral I
2/04
Arteriolar tone
Neural I
2/03
Humoral I
2/03
Local I
2/03
Jugular pulse I
1/98
Coronary blood flow IIII
1/98, 2/99, 1/01, 1/06
Cerebral blood flow IIII
2/99, 1/01, 1/02, 2/05
Pressure Δ in aorta & LV I
1/98
Law of Laplace I
1/99
Pacemaker potentials IIIII
75
Respiratory
Alveolar stability IIII
1/95, 2/97, 2/99, 2/05
Lung volumes I
2/95
Dead space III
1/95, 1/97, 2/04
Oxygen dissociation curve II
1/95, 2/99
Alveolar gas equation IIII
2/95, 2/99, 1/01, 1/02
Control of ventilation IIIIII
1/96, 2/00, 2/01, 2/02, 2/04, 1/05
Neural I
2/98
Humoral I
2/98
Effect of posture on V/Q I
1/96
CO2 transport IIIIIII
2/96, 1/99, 2/99, 1/01, 1/02, 1/03, 1/06
O2 transport II
2/96, 1/06
Regional differences in V & Q IIIIIIIII
1/97, 2/99, 2/00 x 2, 1/01, 2/01 x 2, 2/02, 1/05
Intrapleural P & lung volume ⇒ regional diff V I
2/03
Factors that determine pulmonary blood flow II
1/04 2/06
Compliance III
2/97, 1/01 2/06
Diffusion
Perfusion limited II
1/98, 2/03
Diffusion limited II
1/98, 2/03
Exercise III
2/98, 1/00, 2/04
Pressure changes in inspiration & expiration I
1/99
Pulmonary circulation II
2/99 2/06
76
Renal
Renal blood flow IIIII
1/95, 1/02, 2/04, 2/05 2/6
Buffers II
1/95, 2/05
Dilute urine I
1/96
H secretion III
2/96, 1/05 2/6
K secretion IIII
2/96, 2/98, 2/04, 1/06
Na secretion IIII
2/98, 1/04, 1/05, 1/06
Na & Cl I
2/00
Water excretion I
1/06
Respiratory acidosis I
1/97
Respiratory alkalosis I
1/97
Metabolic acidosis II
1/98, 1/00
Metabolic alkalosis II
1/98, 1/00
Glucose reabsorption II
2/97, 2/98
Osmotic diuresis I
2/97
Regulation of osmolality* III
2/99, 2/02, 2/04
Factors affecting GFR III
1/03, 1/05, 1/06 (general discuss GF)
Acid secretion I
1/03
Response to acute moderate haemorrhage I
1/04
Response to acid load I
1/04
Loop of Henle structure & function I
2/05
ACEM I VIVAS
Here is a selection of viva questions that are similar in style to the ones you will get in the
exam. Many of them are based on past questions, and I have tried to include all the
common questions that have come up over the last few years. Some of the questions are
intentionally difficult, and I have marked them as “5th Question”, just to reassure you just in
case you didn’t feel the question was fair.
Go through these questions on your own, or with your study partner, and practise getting
the answers out succinctly, bearing in mind you have 2 minutes per question. Try and
categorise your answers, to make it easier for the examiners to give you the marks. For
example, if they ask you the causes of a particular disease, pause and think before
blurting the first thing that comes into your mind. Try and give the most common things
first, and leave the obscure answers for the end. It is the common points that will get you
the marks.
If you are asked a question that you really have no idea about, just say, “I’m sorry, I don’t
know the answer to that”. The examiners will either prompt you, and give you a small clue
as to what they want, or they will move onto another question. Remember, the examiner is
there to try and get you through, and if you are struggling, it will be in your best interests to
move onto something that you can score marks on. The examiner will have an eye on the
clock, as it will be his/her responsibility to get you through to the 5th question.
In the viva, there will be two examiners, one asking the question, and one marking your
answers. Try and be confident, and maintain eye contact with the examiner asking the
questions, but also remember to acknowledge the other examiner as well.
79
ANATOMY VIVAS
80
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Axilla
SUBJECT: ANATOMY
TOPIC: Radial N
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Forearm
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Median N
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Sciatic N
SUBJECT: ANATOMY
TOPIC: Pelvis
SUBJECT: ANATOMY
TOPIC: Knee
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Ankle
SUBJECT: ANATOMY
TOPIC: Foot
SUBJECT: ANATOMY
TOPIC: Foot
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Diaphragm
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Orbit
SUBJECT: ANATOMY
SUBJECT: ANATOMY
SUBJECT: ANATOMY
TOPIC: Vertebrae
PATHOLOGY VIVAS
123
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Apoptosis
SUBJECT: PATHOLOGY
TOPIC: Hypersensitivity
SUBJECT: PATHOLOGY
TOPIC: Hypersensitivity
SUBJECT: PATHOLOGY
TOPIC: Hypersensitivity
SUBJECT: PATHOLOGY
TOPIC: Hypersensitivity
SUBJECT: PATHOLOGY
TOPIC: Complement
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Inflammation
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Malaria
SUBJECT: PATHOLOGY
TOPIC: SARS
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Salmonella
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Measles
SUBJECT: PATHOLOGY
TOPIC: Neoplasia
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Meningitis
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Atherosclerosis
Pathogenesis of atherosclerosis
157
SUBJECT: PATHOLOGY
TOPIC: Aneurysms
SUBJECT: PATHOLOGY
TOPIC: Emphysema
SUBJECT: PATHOLOGY
TOPIC: Asthma
SUBJECT: PATHOLOGY
TOPIC: ARDS
SUBJECT: PATHOLOGY
Arterial thrombosis
Arterial embolism
Venous thrombosis
Nonocclusive ischemia
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: Pancreatitis
SUBJECT: PATHOLOGY
SUBJECT: PATHOLOGY
TOPIC: ATN
PHARM VIVAS
167
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: Pharmacology
TOPIC: Diuretics
SUBJECT: PHARMACOLOGY
TOPIC: GTN
SUBJECT: PHARMACOLOGY
TOPIC: Epinephrine
SUBJECT: PHARMACOLOGY
TOPIC: Antiarrhythmics
SUBJECT: PHARMACOLOGY
TOPIC: Digoxin
SUBJECT: PHARMACOLOGY
TOPIC: B-Blockers
SUBJECT: PHARMACOLOGY
TOPIC: Adenosine
SUBJECT: PHARMACOLOGY
TOPIC: Lignocaine
Excreted in urine
SUBJECT: PHARMACOLOGY
TOPIC: Amiodarone
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
SUBJECT: PHARMACOLOGY
TOPIC: Atropine
SUBJECT: PHARMACOLOGY
TOPIC: Salicylates
SUBJECT: PHARMACOLOGY
TOPIC: Clopidogrel
Severe neutropenia
Haemorrhage
Erectile dysfunction
187
SUBJECT: PHARMACOLOGY
TOPIC: Anticoagulants
Contraindicated in haemophilia,
hypersensitivity, hypertension, IC bleed,
infective endocarditis, TB, ulcers GI, renal
disease
Adverse effects - Increased bleeding.
Transient thrombocytopenia in 25%
Discuss the PK, and toxicity of
warfarin
100% bioavailability
99% albumin bound, VD=0.12L/Kg
Metabolised by liver (conjugation)
Excreted enterohepatic circulation, urine
and stool
Causes haemorrhage, tissue necrosis
188
SUBJECT: PHARMACOLOGY
TOPIC: tPA
SUBJECT: PHARMACOLOGY
TOPIC: Dexamethasone
SUBJECT: PHARMACOLOGY
TOPIC: Penicillin
SUBJECT: PHARMACOLOGY
TOPIC: Trimethoprim
SUBJECT: PHARMACOLOGY
TOPIC: Azithromycin
SUBJECT: PHARMACOLOGY
TOPIC: Oxygen
SUBJECT: PHARMACOLOGY
TOPIC: Suxamethonium
SUBJECT: PHARMACOLOGY
TOPIC: Midazolam
SUBJECT: PHARMACOLOGY
TOPIC: Ketamine
SUBJECT: PHARMACOLOGY
TOPIC: Epilepsy
SUBJECT: PHARMACOLOGY
TOPIC: Phenytoin
SUBJECT: PHARMACOLOGY
TOPIC: Carbamazepine
SUBJECT: PHARMACOLOGY
TOPIC: SSRI
SUBJECT: PHARMACOLOGY
TOPIC: Lithium
SUBJECT: PHARMACOLOGY
TOPIC: Antipsychotics
PHYSIOLOGY VIVAS
204
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
Autoregulation due to
Myogenic mechanism – increase in renal
vascular wall tension stimulates smooth
muscle cells to contract causing
vasoconstriction
Tubuloglomerular feedback – alterations
in flow that occurs with alterations in
arterial pressure lead to stimulation of
JGA. This leads to a feedback loop that
returns RBF to baseline.
Other factors that influence RBF
SNS – controls the tone of afferent and
efferent arteriole. Alpha1 receptors
stimulated to cause vasoconstriction
Angiotensin II - RAA system –
vasoconstriction
Local Mediators – PGE2, PGI2 cause
vasoconstriction
PAH used to measure RBF – completely
eliminated, non toxic. Clearance of PAH
equals RPF.
RBF=RPF/(1-hct)
222
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
TOPIC: Vagus N
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
Dissolved in solution 5%
SUBJECT: PHYSIOLOGY
TOPIC: Compliance
Venous congestion
Fibrosis
COPD
Age
231
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
Oligosaccharidases
Alphadextrinase, isomaltase, lactase,
sucrase, trehelase
Final monosaccharides – alpha-dextrose,
maltotriose, maltose, trehalose, lactose,
glucose, fructose
Describe how carbohydrates are
absorbed
2 Phases – 1) into intestinal mucosal cell,
2) into ICF, capillaries & portal blood
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
SUBJECT: PHYSIOLOGY
TOPIC: Buffers
SUBJECT: PHYSIOLOGY
ANATOMY MCQ
1) Panniculosus adiposus
3) A dermatome is
a)
b) sperated from a discontinuous dermatome by an axial line
c)
d)
e)
a) sacro-iliac joint
b) intervertebral joint
c) sterno manubrial joint
d) epiphyses
e)costal cartilages
a) knee meniscus
b) epiglottis
c) epiphyseal growth plate
d) intervertebral discs
e) articular surface of clavicle
a) costochondral joint
b) intervertebral disc
c) TMJ
241
d) lambdoid suture
e) proximal tibial epiphysis
a) 1-2 micrometere
b) 10 millimetre
c) 12-20 micrometres
d) 5-7 millimetres
e) 20-50 micrometers
a) C5
b) C5, 6
c) C5, 6, 7
d) C6, 7, 8
e) C6, 7
242
a) lymphatics
b) cephalic vein
c) lateral pectoral nerve
d) medial pectoral nerve
e) thoracoacromial artery
a) subscapularis
b) teres minor
c) teres major
d) deltoid
e) serratus anterior
a) capsule
b) long head of triceps
c) glenohumeral ligament
d) coraco-acromial arch
e) gleno-humeral joint
25) Which nerve does not pass through the muscle shown
a) subscapularis
b) teres major
c) teres minor
d) infraspinatus
e) supraspinatus
244
28) In the cubital fossa which of the following is lateral to the radial
artery
a)
b) brachial artery
c) median nerve
d) biceps tendon
e) posterior interosseus nerve
30) Triceps
a) FPL
b) median nerve
c) basilic vein
d) radial artery
e) ulnar nerve
37) Lumbricals
39) Interossei
a)
b) have two heads
c) abduct the fingers
d) chiefly responsible for flexion MCPJ and extension PIPJ
e)
246
a) is quadrilateral in shape
b) inserts to the medial lip of bicipital groove
c) is supplied by all 5 segments of the brachial plexus
d) lies between biceps and the humeral shaft
e) has a head arising from posterior surface clavicle
a)
b) extends into lumbrical canals distally
c)
d) is continuous with common carpal space
e) extends proximally to the origin of FDS
a) Thoraco-acromial
b) superior thoracic
c) posterior circumflex humeral
d) dorsal scapular
e) circumflex scapula
a)
b)
c) has the ulna nerve lying medial to it
d)
e)
247
a)
b) has the ulna nerve lying lateral to it
c) supplies deep palmar arch
d) has common interosseus as it’s major branch
e)
a) tarpezium
b) hamate
c) pisiform
d) scaphoid
e) capitate
a) scaphoid
b) hamate
c) pisiform
d) trapezium
e) triquetral
a)
b) is supplied by the axillary nerve
c) has a multipennate arrangement for maximal range of movement
d)
248
a) superficial epigastric
b) superficial circumflex iliac
c) deep external pudendal
d) superficial external pudendal
e) deep circumflex iliac
a) piriformis
b) gluteus maximus
c) obturator internus
d) obturator externus?
e) gemelli
249
a) metatarsals 1,2,3
b) calcaneum
c) talus
d) navicular
e) cuboid
a) ilio-inguinal nerve
b) obturator nerve
c) medial femoral cutaneous nerve
d) lateral femoral cutaneous
e) genito-femoral nerve
a) inversion/eversion
b) dorsiflexion / plantarflexion
c)
d)
e)
72) All of the following structures pass deep to the superior retinaculum
EXCEPT
75) Popliteus
a)
b)
c) PCL is attached to the medial condyle of the femur
d)
e)
78) By Hilton’s law which nerve does not supply the hip joint
a) anal canal
b) scrotal skin
c) testicles
d) urethra
e) anterior skin distal to umbilicus and above inguinal ligament
80) Muscle of the lower leg which can initiate dorsiflexion and inversion
a) tibialis posterior
b) tibialis anterior
c) peroneus tertius
d) peroneus longus
e) peroneus brevis
252
a) the inguinal nerve does not pass through the deep ring
b)
c)
d)
e)
a) sural nerve
b) dorsalis pedis artery
c) EHL
d) EDL
e) Peroneus tertius
a) Branches of the tibial nerve supply most of the dorsum of the foot
b) The medial plantar nerve supplies a greater area than the lateral
c) Deep peroneal nerve supplies the 3rd digital cleft
d) Sural nerve supplies the medial malleolus
e) Superficial peroneal nerve supplies the 1st inter-digital cleft
a) L3
b) S1
c) L5
d) S2
e) L4
a) the neurovascular bundle lies between the external and internal intercostals
b) the transversus muscle lies between the internal and external intercostals
c) the intercostal artery lies between the nerve and vein
d) the intercostal artery is more superficial than the vein
e) all of the above
a) T6
b) T8
c) T10
d) T12
e) L1
a) vagus nerve
b) superior vena cava
c) right subclavian artery
d) left subclavian artery
e) thoracic duct
a) azygous vein
b) right vagus
c) sympathetic trunks
d) thoracic duct
e) phrenic nerves
a) transversus abdominis
b) rectus abdominis
c) diaphragm
d) external oblique
e) internal oblique
a) superficial inguinal
b) external iliac
c) deep inguinal
d) para-aortic
e) internal iliac
104) All the following are veins which drain the stomach EXCEPT
a) gastroepiploic
b) gastroduodenal
c) right gastric
d) left gastric
e) short gastric
a) splenic vein
b) tips of the 9th costal cartilages
c) lower border of L1
d) spleen
e) superior mesenteric artery
107) Appendix
a) is a retro-peritoneal structure
b) is 25cm in length
c) lies between the levels of L2-L4
d) in it’s 4th part lies to the right of the aorta
e) all of the above
256
110) The main vessel supplying the body of the pancreas is the
116) All the following are branches of the external carotid EXCEPT
a) lingual artery
b) facial artery
c) ascending pharyngeal artery
d) hypoglossal artery
e) superior thyroid artery
117) All the following are branches of the ophthalmic division of the trigeminal nerve
EXCEPT
a) lacrimal nerve
b) infraorbital nerve
c) supraorbital nerve
d) infratrochlear nerve
e) supratrochlear nerve
a) infraorbital nerve
b) external nasal nerve
c) zygomaticofacial nerve
d) auriculotemporal nerve
e) zygomaticotemporal nerve
a) zygomaticotemporal nerve
b)
c)
d)
e)
121) All the following are boundaries of the named triangle EXCEPT
122) All the following are contents of the posterior triangle EXCEPT
a) accessory nerve
b) cervical plexus
c) inferior belly of omohyoid
d) transverse cervical vessels
e) occipital lymph nodes
a) ophthalmic nerve
b) maxillary nerve
c) mandibular nerve
d) vagus nerve
e) glossopharyngeal nerve
124) Which of the following enters into the inferior meatus of the nose
a) frontal sinus
b) ethmoidal sinus
c) maxillary sinus
d) nasolacrimal duct
e) auditory tube
125) A fracture through the roof of the maxillary sinus might result in
sensory loss to the
a) tympanic membrane
b) lacrimal gland
c) upper molar teeth
d) upper incisors and canine teeth
e) skin overlying the zygomatic bone
126) All the following structures pass through the jugular foramen EXCEPT
a) jugular vein
b) glossopharyngeal nerve
c) hypoglossal nerve
d) accessory nerve
e) vagus nerve
127) The motor nuclei of the facial nerve are found in the
a) pons
b) midbrain
c) medulla oblongata
d) cerebellum
e) floor of the 3rd ventricle
129) Cerebrospinal fluid communicates with the subarachnoid space via the
a) 4th ventricle
b) 3rd ventricle
c) subarachnoid granulations
d) choroid plexus
e) tela choroidia
130) Which of the following pathways is not concerned with posture and
movement
a) spinocerebellar
b) vestibulospinal
c) tractus solitarius
d)
e)
a) upper incisors
b) labial gum
c) bridge over the nose
d) upper lip
e) skin of the lower eyelid
a) greater occipital
b) third occipital
c) auriculotemporal
d) supraorbital
e) supratrochlear
a) pterygopalatine
b) geniculate
c) otic
d) ciliary
e) trigeminal
a) It is entirely voluntary
b) The oropharyngeal portion is voluntary
c) Peristalsis speeds as the bolus descends
d) The voluntary stage commences as food enters the oesophagus
e) It is initially voluntary then involuntary
260
a) aryepiglotic
b) transverse arytenoid
c) lateral cricoarytenoid
d) posterior cricoarytenoid
e) cricothyroid
143) Which vessel supplies a branch which passes through the foramen spinosum
a)
b)
c) maxillary artery((((for middle meningeal)))))
d)
e)
262
1. D
2. D
3. B
4. C
5. A
6. C
7. B
8. B
9. D
10. C
11. C
12. D
13. A
14. A
15. D
16. D
17. B
18. E
19. C
20. D
21. B
22. B
23. C
24. – (B)
25. D
26. D
27. B
28. D (E)
29. D
30. B
31. E (A)
32. C
33. E
34. E
35. E
36. A
37. D
38. C
39. D
40. D
41. C
42. –
43. –
44. C
45. D
46. – (D)
47. C
48. D (?C)
49. E
50. C
51. B
52. D
53. C (+E)
54. B
55. E
56. A
57. D
58. C&E
59. B&E
60. B
61. E
62. C
63. A
64. E (A)
65. E
66. B (?C)
263
67. A
68. E
69. C
70. A
71. E
72. C
73. A
74. D
75. B
76. D (C)
77. C
78. E
79. C
80. B
81. A
82. A
83. D
84. D (B)
85. E
86. C
87. E
88. C
89. E
90. B
91. C
92. C
93. C
94. C
95. B
96. E
97. B
98. C
99. B
100. C
101. C
102. A
103. B
104. B
105. B
106. D
107. E
108. B
109. B
110. B
111. C
112. C
113. E
114. E
115. –
116. D
117. B
118. D
119. A
120. B
121. A
122. E (B)
123. A (B)
124. E(B)
125. E (D)
126. C
127. A
128. D
129. A
130. C
131. –
132. C
264
133. A
134. D
135. E
136. D
137. C
138. C
139. D
140. D
141. D
142. B
143. C
144. -
265
PATHOLOGY MCQ
1) Hypertrophy
a) cell swelling
b) chromatin condensation
c) formation of cytoplasmic blebs
d) lack of inflammation
e) phagocytosis of apoptotic bodies
3) Dystrophic calcification
a) dispertion of ribosomes
b) cell swelling
c) nuclear chromatin dumping
d) lysosomal rupture
e) cell membrane defects
5) Metaplasia
7) Pinocytosis
a)
b)
c)
d) glandular epithelium of pubertal breasts
e)
9) Ribosomes
a) have 3 subunits
b) have 30% DNA
c) synthesise haemoglobin
d)
e)
a) arteriolar dilatation
b) arteriolar constriction
c) oedema
d) leucocyte migration
e) blood flow stasis
13) Leucocytes move into the tissues from the vasculature (extravasation )
a) blushing
b) excersise
c) arteriolar dilation
d) inflammatory mediators
e) still present after sympathectomy
a) histamine
b) seretonin
c) prostaglandins
d) oxygen free radicals
e)
a) neutrophils
b) eosinophils
c) macrophages
d) T-cells
268
e)
a) B-cell
b) T-cell
c)
d)
e)
22) Granulocytes
a)
b)
c)
d)
e)
23) Oncogenes
a)
b)
c)
d)
e)
24) Dysplasia
25) Metastasis
29) Regarding chronic inflammation all of the following are true EXCEPT
a) monocytes
b) T-cells
c) B-cells
d) Eosinophils
e) Plasma cells
a) small intestine
b) oesophagus
c) lung
d) kidney
e) sigmoid colon
a)
b)
c) haemosiderin deposition in macrophages
d)
e)
a)
b)
c) neutrophils proliferate at the wound margins at the same time as epitheleal
proliferation occurs
d)
e)
36) Which occurs first in fracture healing
a) neutrophil invasion
b) procallus formation
c) woven bone ossification
d) lamellar bone ossification
e) collagen deposition
a) is rarely idiopathic
b) associated with diving injuries
c) rarely involves ischaemia
d)
e)
a) thrombocytosis
b) a bleeding diathesis presentation in a patient with malignancy
c)
d)
e)
b)
c)
d)
e)
a)
b)
c) mortality of greater than 20 %
d)
e) petechial rash, non-thrombocytopenic
49) T lymphocytes
a) cell mediated
b) prevented largely by cross-matching blood
c) controlled by immunosuppressive drugs
d)
e)
51) All the following are type 1 hypersensitivity primary mast cell
mediators EXCEPT
a) histamine
b) tryptase
c) heparin
d) platelet activating factor
e) eosinophil chemotactic factor
a) live virus
b) attenuated virus
c) adsorbed toxin
d) activated T-cells
e) all of the above
a) homosexual males
b) IV drug abusers
c) Haemophilliacs
d) Heterosexual contact
e) Recipients of blood products
a) PCP
b) Atyoical mycobacterium
c) CMV
d) Mycoplasma pneumonia
e)
a)
b)
c)
d) polyclonal hypergammaglobulinemia
e)
a) food poisoning
b) osteomyelitis
c) carbuncles
d) scarlet fever
e) scalded skin syndrome
a) HSV
b) HBV
c) HIV
d) EBV
e) VZV
a)
b)
c) may result in glomerulonephritis 3 weeks post infection
d)
e)
a) aplastic anemia
b) SLE
c) Meningococcemia
d) HIV
e) EBV
a)
b)
c) HbeAg is associated with viral replication
d)
e)
64) In hepatitis B
65) Hepatitis C
a) leprosy
b) toxoplasmosis
c) tuberculosis
d) typhoid fever
e) CMV
a) is exemplified by streptokinase
b) si the cause of the severe form of diptheria
c) is the cause of gas gangrene
d) induces the production of TNF
e) is the outer cell wall of gram positive bacteria
73) In malaria
a)
b)
c)
d) principally affects the endothelium
e)
a) GI mucosa
b) CNS
c) Lymph and haemopoetic
d) Bone
e) Lungs
a) vitamin D
b) vitamin B12
c) vitamin E
d) vitamin K
e) vitamin B6
a) pyridoxine
b) vitamin A
c) riboflavin
d) vitamin B1
e) niacin
277
79) Decreased levels of B12 are associated with all the following EXCEPT
a) autoimmune gastritis
b) crohns disease
c) subacute combined degeneration of the cord
d)
e)
a) anterior-LH-basophils
b) posterior-vasopressin-basophils
c) anterior-GH-basophils
d)
e)
a) graves disease
b) hypothyroidism
c) acromegaly
d)
e)
a) posterior-prolactin-acidophils
b) posterior-vasopressin-basophils
c) anterior-LH-basophils
d)
e)
a) panacinar
b) centriacinar
c) distal acinar
d) irregular
e) none of the above
a)
b)
c) viral infections
d)
e)
a)
b)
c)
d)
e)
a) pneumothorax
b) asthma
c) CCF
d) Peritonitis
e) Pleural effusion
a) leukocyte infiltration
b) decreased goblet cell number
c) smooth muscle hypertrophy
d) increased mucosal gland depth ( REID index)
e)
a) lung
b) larynx
c) oesophagus
d) pancreas
e) lip, oral, and pharynx
a) lung cancer
b) stroke
c) cancer of the bladder
d) MI
e) COPD
96) In emphysema
a) spontaneous abortion
b) atherosclerosis
c) bladder carcinoma
d) chronic liver disease
e)
a)
b)
c)
d) particle deposition in alveolar macrophages
e)
a) apex
b) base
c) hilum
d) lower zone of upper lobe
e) peripherally
a) pallor at 24 hours
b) wavy fibres are found centrally
281
a) diffuse fibrosis
b) hyperplasia
c) decreased sarcomeres
d) increased capillary density
e) increased capillary/myocyte ratio
a) macrophages
b) foam cells
c) leukocytes
d) smooth muscle cells
e)
107) All of the following are major risk factors for atherosclerosis EXCEPT
a) obesity
b) hyperlipidemia
c) smoking
d) hypertension
e) diabetes
a) actinomycosis
b) as
c) as
d) candida
e) blatomycosis
a) myocardial depression
b) vasoconstriction
c) DIC
d) ARF
e) ARDS
a)
b)
c)
d) decreased capillary hydrostatic pressure
e)
114) Patient who has a normal blood pressure post MI must have
a) vitamin A deficiency
b) niacin deficiency
c) vitamin D deficiency
d) thiamine deficiency
e) vitamin C deficiency
118) Thromboctopenia
a) hypoxia
b) decreased ATP
c) increased CO2
d) catecholamines acting on alpha 1 receptors
e) acetylcholine stimulation
a) myocardial ischaemia
b) arrhythmia
c) thiamine deficiency
d)
e)
121) Which risk factors have the greatest association with atherosclerosis
a) hypotension
b) decreased blood volume
c) cellular hypoxia at a tissue level
d) infection
e) cardiac failure
124) The cause of fluid retention peripherally with congestive cardiac failure
is
a) increased renin
b) increased GFR
c) increased angiotensin 2
d) increased aldosterone
e)
a) Curschmann spirals
b) Ito cells
c) Aschoff bodies
d) Nutmeg cells
e) Reed-sternberg cells
126) Bradykinin
a) carbuncles
b) mucormycosis
c)
d)
e) all of the above
a) early insulinitis
b) not affected by pregnancy
c) decreased peripheral receptor sensitivity
d) less than 50 % concordance in twins
e) 90 % of patients displaying antibodies to insulin receptors within 1 year of
diagnosis
135) In cirrhosis
a)
b) reorganised liver vasculature with scarring
c)
d)
e)
a)
b) 60 % of renovascular hypertension is due to fibromuscular hyperplasia
c) malignant hypertension only arises if previous hypertension
d) onion skinning correlates with degree of renal failure
e)
a)
b)
c)
d)
e)
a) it is irreversible
b) one loses the ability to concentrate urine
c) urine has a high sodium concentration
d) the urine is hyperosmolar
e) the favoured theory of it’s generation involves increased renal blood flow
144) Urolithiasis
145) In pyelonephritis
a) osteoporosis
b) general obesity
c) hypotension
d)
e)
a) Hyperthyroidism
b) Neoplasm
c) Folate and B12 deficiency
d) Pregnancy
e) EBV
a)
b)
c)
d) acanthosis nigricans
e)
150) Hypothyroidism is associated with all of the following EXCEPT
a) cretinism
b)
c)
d) decreased hair growth
e) cold intolerance
a) SLE
b) Arthus reaction
c) Anaphylaxis
d) Graft rejection
e) Goodpastures
288
152) Myelefibrosis
a) medullary
b) follicular
c) papillary
d) anaplastic
e) squamous
1. E (C)
2. A
3. E
4. E
5. D
6. A
7. E
8. D
9. C
10. E
11. B
12. E
13. B (A)
14. D (E)
15. D
16. C&E
17. C
18. A ?E
19. D
20. D
21. B
22. –
23. –
24. C
25. A ?E
26. A
27. E?
28. B
29. – (B)
30. A
31. D
32. D
33. C
34. C
35. C
36. A
37. B
38. B (A)
39. D
40. E
41. B
42. E
43. C
44. B
45. A
46. - ?D
47. A
48. E
49. A (D)
50. –
51. D
52. D
53. E
54. D
55. A (D)
56. D
57. D
58. E
59. D
60. C
61. C
62. C
63. C
64. E
65. E
66. B
290
67. B
68. A
69. A
70. D
71. B
72. D (E)
73. B
74. D
75. C
76. C,D
77. C
78. E
79. A
80. B
81. A
82. B,C
83. C
84. B
85. B
86. C
87. –
88. B
89. C
90. B
91. A
92. D
93. E
94. A (D)
95. A
96. C
97. A
98. E
99. A
100.D
101.D
102.D
103.E
104.A
105.A
106.B
107.A
108.E
109.D
110.D
111.A (B)
112.C
113.D
114.B
115.B
116.D
117.D (A)
118.A
119.A
120.C
121.A,E (A)
122.A,C
123.E
124.D
125.C
126.B
127.E
128.D
129.B (?C)
130.– (E)
131.C
132.B
291
133.A
134.C
135.D
136.B
137.D
138.C
139.B
140.D
141.–
142.–
143.D
144.D
145.A
146.A
147.E
148.A
149.D
150.D
151.D
152.C
153.C
154.E
292
PHARMACOLOGY MCQ
3) Calculate the half life of digoxin in a patient with a renal clearance of 8.4L/min and
Vd of digoxin of 5 L/Kg in a 70 Kg man
a) 8 hours
b) 14 hours
c) 29 hours
d) 36 hours
e) 44 hours
a) 1 minute
b) 5 minutes
c) 10 minutes
d) 30 minutes
e) 120 minutes
a) methylation
b) acetylation
c) oxidation
d) glucuronidation
e) sulphonation
a) 1-2 minutes
b) 2-4 minutes
c) 40-60 minutes
d) 60-90 minutes
e) more than 2 hours
9) 5 ml of 2% wv is equal to
a) 10 mg
b) 100 mg
c) 200 mg
d) 20 mg
e) 40 mg
a) cholestyramine
b) barbituates
c) benzodiazepines
d) rifampicin
e) amiodorone
294
14) Streptokinase
a) is a complex lipopolysaccharide
b) is synthesised by the human kidney
c) binds to the proactivator plasminogen
d) activates the plasminogen that is bound to fibrin
e) is more dangerous than tPA in those over 75 years of age
a) cephalosporins
b) benzodiazepines
c) barbituates
d)
e)
17) All of the following are known to potentiate the effects of oral
anticoagulants EXCEPT
a) cimetidine
b) ceftriaxone
c) rifampicin
d) metronidazole
e) trimethoprim
18) Heparin
20) Ticlodipine
a)
b)
c)
d) inhibits ADP induced platelet aggregation
e)
21) Warfarin
a) TIMI trial showed increased incidence of GI bleed as the major side effect of
administration
b) Aminocaproic acid inhibits fibrinolysis
c)
d)
e)
a) cefaclor
b) ceftazidime
c) cephalexin
d) cefotaxime
e) cephalothin
25) The cephalosporin with the highest activity against G +ve bacteria is:
a) cefuroxime
b) cefotaxime
c) cefaclor
d) cefipime
e) cephalothin
296
26) Which of the following antibiotics does not possess a beta-lactam ring
a) penicillins
b) cephalosporins
c) fluoroquinolones
d) carbapenams
e) monobactams
27) Which of the following drugs does not exert its action by inhibiting cell
wall synthesis
a) vancomycin
b) erythromycin
c) penicillin
d) ceftriaxone
e) imipenem
28) Erythromycin
29) Erythromycin
a)
b)
c)
d) is effective against campylobacter jejuni
e)
30) Metronidazole
a) vitreous humour
b) CSF with normal meninges
c) Proximal tubular fluid in kidneys
d)
e)
a) HSV
b) CMV
c) HZV
d) Varicella
e) None of the above
36) Acyclovir
37) Amantadine
a) is an antiviral drug
b) produces insomnia not sedation
c) causes acute psychosis
d) potentiates dopaminergic function
e) all of the above
38) Doxycycline
39) Metronidazole
a) norfloxacin
b) trimethoprim
c) rifampicin
d) sulfasalazine
e) chloramphenicol
41) Gentamicin
a) is not nephrotoxic
b) increases the effect of neuromuscular junction blocking drugs
c)
d)
e)
42) Gentamicin
a)
b) may be given orally
c) enters cells by an oxygen dependent influx
d) has a large theraputic index
e)
a) lignocaine
b) prilocaine
c) bupivicaine
d) benzocaine
e) cocaine
a) warfarin
b) heparin
c) verapamil
d) ticlodopine
e) digoxin
a) verapamil
b) digoxin
c) imipramine
d) codeine
e) chlorpromazine
299
a) cefuroxime
b) cefotetan
c) cefazolin
d) cefaclor
e) ceftriaxone
48) Which of the following drugs does not cause the same effect
a) muscarine
b) acetylcholine
c) hyoscine
d) carbachol
e) methacholine
49) Which of the following side effects for given drugs is wrong
50) A man presents with dilated pupils, confusion, hyperpyrexia. Which of the
following drugs would not account for this
a) atropine OD
b) morphine
c) datura
d)
e)
51) A healthy young man recieves a normal dose of a drug which induces
midriasis and increased systolic blood pressure . The drug could be
a) adrenaline
b) acetylcholine
c)
d)
e)
a) lipid solubility
b) local anaesthetic action
c) half life of 3-6 hours
d) bioavaliability of 30 %
e) beta sympathetic selectivity
300
a) atropine OD
b) amphetamine OD
c) aspirin OD
d) tricyclic OD
e) angels trumpet
a) nicotinic antagonist
b) muscarinic antagonist
c) cholinomimitic
d) adrenergic agonist
e) adrenergic antagonist
a) potassium supplements
b) frusemide
c) ACE inhibitor
d) Suxamethonium
e) Spironalactone
a) miosis
b) confusion
c) diarrohea
d) GIT haemorrhage
e) Bronchorrhea
a) adenosine
b) high potassium
c) propranolol
d) enalapril
e) none of the above
59) Which does not prolong the refractory period of normal cells
a) amiodorone
b) lignocaine
c) quinidine
d) sotalol
e) procainamide
60) Verapamil
a) is a positive inotrope
b)
c) inhibits activated and inactivated sodium channels
d) is a dihydropyridone
e)
61) The calcium channel blocker with the most rapid onset of action when
given orally is
a) diltiazem
b) nifedipine
c) verapamil
d) felodopine
e) nicardipine
62) Sodium nitroprusside
63) Methyldopa
a)
b)
c)
d) is a potent vasoconstrictor
e) can cause Coombs positive test after prolonged use
65) Digoxin
a)
b)
c)
d) is a positive inotrope
e)
302
66) All of the following may increase the effect of digoxin EXCEPT
a) amiodorone
b) frusemide
c) carbamazepine
d) verapamil
e) quinidine
68) Hydralazine
a) propranolol
b) atenolol
c) metopralol
d) pindolol
e) sotalol
70) Propranolol
71) Nitrates
a) metoprolol
b) verapamil
c) sotalol
d) flecanide
e) bretylium
303
a) felodipine
b) nitroprusside
c) indapamide
d) prazosin
e) hydralasine
a)
b)
c)
d) spironolactone
e)
a) ethanol
b) amiloride
c) lithium
d) aldosterone
e) triamterene
a) atropine
b) adrenaline
c) salbutamol
d) theophylline
e) disodium cromoglycate
a) hyperkalemia
b) decreased PO2 initially
c) skeletal muscle tremor
d) nervousness
e) weakness
82) Ipratropium
a) causes miosis
b) is well absorbed orally
c) inhibits mast cells
d) readily enters the CNS
e) onset of effect within 10 minutes
a) fluoxeteine
b) amitryptiline
c) moclobemide
d) ondansotron
e) sumatriptan
a)
b)
c)
d) they are preferred in the treatment of obsessive compulsive disorders over
TCA’s
e)
86) Barbituates act by
a)
b)
c) opening GABA chloride ion channels
d)
e)
305
a) vigabatrin
b) quinidine
c) sodium valproate
d) metoprolol
e) imipramine
a) paroxetine
b) sertraline
c) trazodone
d) moclobemide
e) clomipramine
a) imipramine
b) moclobenide
c) sertraline
d) trazodone
e) paroxeteine
91) Fluoxeteine
a) carbemazepime
b) non-compliance
c) disulfiram
d) erythromycin
e) hypoalbuminemia
93) Carbemazepime
95) The opiate associated with seizures when given in high dose to
patients with renal failure is
a) morphine
b) pethidine
c) methadone
d) fentanyl
e) codeine
a) diazepam
b) midazolam
c) temazepam
d) phenobarbitone
e) chloral hydrate
a) chlorpromazine
b) lorazepam
c) risperidone
d) haloperidol
e) clozapine
307
a) miosis
b) nausea
c) cough supression
d) analgesia
e) respiratory depression
103) Cannabinoids
a) produce tachycardia
b) have an antipsychotic action
c) act on a number of non-specific receptors
d) constrict the pupils
e) all of the above
104) Pralidoxime
105) Pentamidine
a)
b)
c)
d) is toxic to pancreatic beta cells
e)
a) tetracaine
b) lignocaine
c) bupivicaine
d) etidocaine
e) prilocaine
308
107) Metformin
a)
b)
c) does not require functioning pancreatic beta cells for its action
d)
e)
a) physostigmine
b) edrophonium
c) neostigmine
d) parathion
e) malathion
a) phencyclidine
b) LSD
c) Propofol
d) Thiopentone
e) Enflurane
a) lignocaine
b) bupivicaine
c) benzocaine
d) prilocaine
e) etidocaine
113) The muscle relaxant most commonly associated with tachycardia is low
dose
a) Suxamethonium
b) Atracurium
c) Vecuronium
d) Pancuronium
e) Tubocurare
309
a) hydrocortisone
b) prednisolone
c) methylprednisolone
d) dexamethasone
e) betamethasone
115) Which of the following drugs is the most safe to give in pregnancy
a) heparin
b) lithium
c) phenytoin
d) captopril
e) gentamicin
116) Cisapride
a)
b)
c)
d) metabolism of paracetamol requires glutathione
e)
118) Paracetamol
119) Dextropropoxyphene
a)
b)
c)
d)
e) is structurally related to methadone
120) Allopurinol
a)
b)
c)
d) is metabolised by xanthine oxidase
e)
310
121) Prochlorperazine
a)
b)
c)
d) can cause neuroleptic malignant syndrome
e)
a) sedation
b) postural hypotension
c) nausea and vomiting
d) LA
e) All of the above
a)
b)
c)
d)
e)
a) typhoid
b) tetanus
c) HBV
d) Rabies
e) Measles
311
a) weak anti-diuresis
b) increased strength of muscle contraction
c) negative inotropic effect
d) medullary depression
e) stimulation of cell surface adenosine receptors
a) nitrous oxide
b) halothane
c) isoflurane
d) methoxyflurane
e) ketamine
a) midazolam
b) glycopyrolate
c) propofol
d) fentanyl
e) etomidate
a) propfol
b) isoflurane
c) suxamethonium
d) atracurium
e) ketamine
a) atracurium
b) mivacurium
c) pancuronium
d) vecuronium
e) rocuronium
312
a) sulindac
b) piroxicam
c) gemfibrozil
d) ketorlac
e) diflusinal
a) streptomycin
b) kanamycin
c) metronidazole
d) cephalexin
e) phenoxymethylpenicillin
a)
tolbutamide and glipizide are sulphonylureas
b)
chlorpropramide has a half life of 4-6 hours
c)
metformin is more effective once weight is controlled
d)
glipizide has one of the longest half lives
e)
lactic acidosis is more common with metformin than phenformin
137) Which of the following has its metabolism inhibited by limiting liver
blood flow
a) verapamil
b) lignocaine
c) labetalol
d) trimethoprim
e) propoxyphene
a) bradycardia
b) pulmonary infiltrates
c) fever
d) hypotension
e) anaphylaxis
139) Theophyline
a) is a positive chronotrope
b) reduces GFR
c) si thought to increase blood viscosity
d) is less potent than aminophlline
e) has a Vd of 10L/kg
a) salbutanol
b) salmeterol
c) sotalol
d) terbutaline
e) isoprotenerol
313
1. E
2. A
3. –
4. E
5. D
6. E
7. C
8. D
9. B
10. E
11. B
12. E
13. E
14. C
15. B
16. B
17. C
18. C
19. C
20. D
21. D
22. B
23. A
24. A
25. E
26. C
27. B
28. E
29. D
30. B
31. C
32. A
33. B
34. B
35. B
36. C
37. E
38. B
39. A
40. E
41. B
42. C
43. B
44. B
45. B
46. B
47. B
48. C
49. D
50. B
51. A
52. – (E)
53. C
54. B
55. B
56. B
57. A
58. C
59. B
60. C
61. B
62. A
63. E
64. D
65. D
66. C
314
67. D
68. A
69. A
70. C
71. B
72. D
73. A
74. C
75. D
76. A (C)
77. E
78. E (B)
79. B, D
80. E
81. A
82. E ?A
83. D
84. E
85. D
86. C
87. – (?B)
88. E
89. D
90. A
91. B
92. C
93. D
94. E
95. A (B)
96. D
97. E
98. D (B)
99. D
100. A
101. D
102. E
103. A
104. A
105. D
106. A
107. C
108. C
109. E
110. B
111. A
112. C
113. D
114. E (A)
115. A
116. C
117. D
118. –
119. E
120. D
121. D
122. A
123. E
124. –
125. B
126. D
127. E
128. B
129. D (E)
130. A
131. B
132. C
315
133. C
134. C
135. D
136. A
137. A,B,C,E
138. D
139. A
140. B
316
PHYSIOLOGY MCQ
a) intracellular
b) interstitial
c) extracellular
d) transcellular
e) vascular
a) decreased magnesium
b) increased phosphate
c) increased potassium
d) decreased sodium
e)
a) increased potassium
b) decreased phosphate
c) increased phosphate
d) decreased sodium
e)
6) Anion gap is
a) 1
b) 10
c) 0.1
d) 100
e) 0.01
a) 0.0001meq/L
b) 0.00004 meq/L
c) 0.0004 meq/L
d) 0.0002 meq/L
e) 0.00002 meq/L
10) Regarding basic physiological measures all of the following are true
EXCEPT
13) With regard to the action potential of a neuron with an RMP of -70mV
a) calcium influx
b) sodium influx
c) potassium influx
d) chloride influx
e) potassium efflux
a) it hyperpolarises
b) the tension is due to elastic forces only
c) it depolarises
d) relaxation occurs
e) it is an example of a multi-unit smooth muscle
a) fibrinogen
b) haemoglobin
c) albumin
d) gamma globulin
e) alpha 1 antitrypsin
a) albumin
b) fibrinogen
c) gamma globulins
d) complement
e) erythropoetin
22) The part of the cardiovascular system with the largest cross sectional surface area
is
a) arteries
b) capillaries
c) large veins
d) aorta
e) vena cava
23) All of the following are true of skeletal and cardiac muscle EXCEPT
a) calcium influx
b) chloride influx
c) sodium influx
d) potassium efflux
e) chloride efflux
a) 0.1
b) 0.2
c) 0.3
d) 0.4
e) 0.5
a) 400
b) 800
c) 1200
d) 1600
e) 2000
a)
b)
c)
d)
e) hyperosmolarity
34) Which of the following would be best used for measuring GFR
a) radiolabelled albumin
b) inulin
c) deuterium oxide
d) tritium oxide
e) mannitol
Plasma PAH 90: Urine PAH 0.3: Plasma inulin 35: urine inulin 0.25: Urine flow 1 ml/
min: Hct 40%
a) 120
b) 140
c) 180
d) 240
e) 400
36) Where in the renal tubules does the intratubular and interstitial osmolality hold
the same values
a)
b)
c)
d) potassium is reabsorbed actively in the proximal tubule
e)
a) chloride
b) bicarbonate
c) glucose
d) potassium
e) calcium
322
40) In chronic acidosis the major adaptive buffering system in the urine is
a) carbamino compounds
b) bicarbonate
c) ammonium
d) histidine residues
e) phosphate
41) The following blood gases represent pH 7.32, pCO2 31mmHg and HCO3-
20mmol/L
a) acetazolamide treatment
b) diuretic use
c) diarrhoea
d)
e)
a) PaCO2
b) K+ concentration
c) Carbonic anhydrase
d) Aldosterone
e) Calcium
323
a) a passive process
b) closely associated with potassium
c) the same in all nephrons
d) occurs predominantly in the distal tubule
e) resembles glucose reabsorption in the intestine
a) 20
b) 10
c) 1
d) 0.1
e) 0.2
50) Which of the following best describes the changes found in uncompensated
respiratory alkalosis
a) fibrosis
b) consolidation
c) emphysema
d) alveolar oedema
e) high expanding pressures
a) O2 tension
b) CO2 tension
c) H+ concentration
d) H+ conc and CO2 tension
e) H+conc, CO2 tension and PO2
a) carboamino groups
b) dissolved in blood by Henrys law
c) haemoglobin
d) bicarbonate
e) none of the above
58) The haemoglobin dissociation curve moves up and to the left with
a) increased H+ concentration
b) hypothermia
c) increased 2,3 DPG
d) hypercarbia
e) all of the above
325
61) Which of the following is associated with the least increase in airway
pressure
a) forced expiration
b) nasal breathing
c) very low lung volumes
d)
e)
62) Surfactant
a) increases compliance
b) is produced by type 1 pneumocytes
c)
d)
e)
64) What is the PO2 of alveolar air with a CO2 of 64 and a respiratory
quotient of 0.8
a) 35
b) 52
c) 69
d) 72
e) 80
326
65) What is the compliance of a lung if a balloon is blown up with 500ml of air with a
pressure change from -5 to -10
a) 0.1
b) 1
c) 10
d) 100
e) 200
66) When walking at a steady pace the increase in respiratory rate is due to
a) decreased PO2
b) increased CO2
c) increased pH
d) increased pH CSF
e) none of the above
a) altitude
b) forced expiration
c)
d)
e)
68) What is the maximal volume left in the lung after maximal forced
expiration
a) 0.5
b) 1.0
c) 2.0
d) 3.0
e) 3.5
69) Compliance is
a)
b)
c)
d) dependent on lung volume
e)
71) Permanent high altitude is associated with all of the following EXCEPT
72) Increased 2,3 DPG occurs with all the following EXCEPT
a) chronic hypoxia
b) acidosis
c) androgens
d) thyroid hormones
e) none of the above
74) EDRF
a) a diameter of 10-20 mm
b)
c)
d)
e) a basement membrane
78) Which of the following have a specific beta effect on smooth muscle contraction
a) adrenaline
b) noradrenaline
c) isoprenaline
d)
e)
a) sweating
b) defecation
c) urination
d) radiation/conduction
e)
a) capillaries
b) large arteries
c) pulmonary circulation
d) the heart
e) venules and veins
83) Which of the following organs receive the largest amount of the bloods
circulation per kg of tissue
a) heart
b) kidney
c) brain
d) liver
e) adrenal
a)
b)
c)
d)
e) it is similar to the ECF of the brain
329
a) acidosis
b) barbituates
c) hypercarbia
d) bradycardia
e) glucagon
a) sleep
b) excersise
c) pregnancy in the first trimester
d) sitting from a lying position
e) all of the above
87) With regard to the cardiac cycle
a) AV node
b) Atrial pathways
c) Bundle of His
d) Purkinje system
e) Ventricular system
91) Which of the following are not part of the compensatory mechanism
activated by haemorrhage
a) increased erythropeitin
b) increased insulin secretion
c) increased vasopressin secretion
d) increased glucacorticoid secretion
e) increased renin secretion
330
a) exercise
b) eating
c) sleep
d)
e)
93) A young fit man goes from sitting to running with full exertion. His stroke
volume will increase by
a) 400%
b) 700%
c) 2000%
d) less than 200%
e) 1000%
a)
b)
c)
d) isovolumetric contraction phase immediately follows the phase of atrial
systole
e)
a) decreased ADH
b)
c)
d) increased thoracic pumping
e)
a) atrial systole
b) atrial contraction against a closed tricuspid valve in complete block
c) the increase in intrathoraci pressure during expiration
d) transmitted pressure due to tricuspid bulging in isovolumetric contraction
e) the rise in pressure before the tricuspid valve opens in diastole
a) local K+ accumulation
b) systemic hypoxia
c) lactate
d) increased CO2 tension
e) decreased pH
101) Under basal conditions the percentage of the hearts caloric needs met
by fat is
a) 70%
b) 60%
c) 50%
d) 40%
e) 30%
102) Baroreceptors
a)
b)
c)
d)
e)
103) Bradykinin
a)
b)
c)
d) vitamins A, D and K are absorbed in the small intestine
e)
332
a) it is present in animals
b) plants contain cholesterol
c) it is essential to the structure of the cell membrane
d) it is a precursor to bike acids
e)
a) stomach / duodenum
b) jejenum
c) ileum
d) ascending colon
e) descending colon
a) essential
b) non-essential
c) modulatory
d) passive
e)
110) Which of the following does not utilise the same receptor in its mechanism of
action
a) insulin
b) glucagon
c) PTH
d) ACTH
e) They all have the same mechanism of action
333
a) glycine
b) histidine
c) tryptophan
d) tyrosine
e) cysteine
a) mannose
b) glucagon
c) noradrenaline
d) leucine
e) acetylcholine
115) Insulin
116) Lymph
a)
b)
c)
d) renal function
e)
334
a) hypophos phatemia
b) the formation of kidney stones
c) a self limiting illness
d) neuromuscular hyperexcitability
e) cystic bone disease
a) seretonin
b) tryptophan
c) glycine
d) GABA
e) Glutamate
a) serotonin
b) glutamate
c) adenosine
d) insulin
e) glucagon
a) sodium
b) chloride
c) sodium and magnesium
d) magnesium
e) all of the above
a)
b)
c)
d) is produced by the gastric parietel cells
e)
a) GABA
b) Glutamate
c) Aspartate
d) Glycine
e) None of the above
a) G cells
b) Chief cells
c) Parietal cells
d) K cells
e) S cells
a) stomach
b) proximal small bowel
c) colon
d) distal small bowel
e) ileum
1. D
2. A
3. A
4. B
5. –
6. B
7. B
8. B
9. B
10. D
11. C (A)
12. B
13. B (D)
14. C
15. E
16. E
17. C
18. C
19. B
20. A
21. C
22. B
23. B
24. B
25. C
26. B
27. A
28. C
29. B
30. B
31. C
32. E
33. B
34. B
35. –
36. B
37. A
38. D
39. A
40. C
41. E
42. B
43. D
44. D
45. E
46. E
47. C
48. C
49. B
50. B
51. E (B)
52. C
53. C
54. B
55. E
56. B
57. D
58. B
59. E
60. A
61. C
62. A
63. E
64. C
65. A (D)
66. E
338
67. A
68. B
69. D
70. B
71. A
72. B
73. B
74. A
75. B (A)
76. E
77. A
78. C
79. E
80. D
81. C
82. E
83. B
84. E
85. E
86. D
87. A
88. E
89. E
90. D
91. B
92. C
93. D
94. D
95. D
96. C
97. E
98. D
99. D
100. B
101. B
102. –
103. C
104. D
105. B
106. C
107. A
108. B
109. B
110. A
111. C
112. B
113. D
114. C
115. C
116. B
117. D
118. C
119. D
120. A
121. A
122. A
123. B
124. C
125. D
126. B
127. D
128. E
129. A
130. B
131. E
132. C
339
133. E
134. B
135. D